{"count":20,"next":null,"previous":null,"results":[{"url":"https://lda.gov/api/v1/filings/2a724a0a-e0ad-4918-ac11-b31bc71cfd7c/","filing_uuid":"2a724a0a-e0ad-4918-ac11-b31bc71cfd7c","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/2a724a0a-e0ad-4918-ac11-b31bc71cfd7c/print/","filing_document_content_type":"text/html","income":null,"expenses":"299699.00","expenses_method":"C","expenses_method_display":"C","posted_by_name":"Jonathan Heafitz","dt_posted":"2026-04-20T13:11:26-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"325 7th Street NW, 9th Floor","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":31348,"url":"https://lda.gov/api/v1/registrants/31348/","house_registrant_id":34004,"name":"PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION","description":"Issues relating to prescription drug benefits","address_1":"325 7th Street NW, 9th Floor","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JONATHAN HEAFITZ","contact_telephone":"+1 202-756-5735","dt_updated":"2026-07-22T16:58:34.643878-04:00"},"client":{"id":138221,"url":"https://lda.gov/api/v1/clients/138221/","client_id":12,"name":"PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION","general_description":"no change","client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-07-01"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"S.1637/H.R 7871; Medicaid VBPs for Patients Act S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S. 2617/H.R. 1244; Reducing Drug Prices for Seniors Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 1041; Affordable Prescriptions for Patients Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3345; PBM Price Transparency and Accountability Act H.R. 4317; PBM Reform Act H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services H.R. 8143; Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":44250,"prefix":"mr","prefix_display":"MR.","first_name":"JONATHAN","nickname":null,"middle_name":"M","last_name":"HEAFITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143598,"prefix":null,"prefix_display":null,"first_name":"LUCIA","nickname":null,"middle_name":null,"last_name":"LEBENS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147046,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"THREADGILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149676,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"BUSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153596,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MARIN","suffix":null,"suffix_display":null},"covered_position":"Republican Staff Director, House Oversight and Government Reform Committee","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S.1637/H.R 7871; Medicaid VBPs for Patients Act S. 2355/H.R. 5582; Patients Deserve Price Tags Act S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S. 526; Pharmacy Benefit Manager Transparency Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 1041; Affordable Prescriptions for Patients Act S. 1095; Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act S. 1096; Preserve Access to Affordable Generics and Biosimilars Act S. 1097; Interagency Patent Coordination and Improvements Act of 2025 S. 1414; Expedited Access to Biosimilars Act S. 2617; Reducing Drug Prices for Seniors Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3345; PBM Price Transparency and Accountability Act S. 3349; PBM Disclosure Act S. 3549; PBM Fiduciary, Accountability, Integrity, and Reform Act S. 3822; Break Up Big Medicine Act H.R. 1244; Reducing Drug Prices for Seniors Act H.R. 2214; Delinking Revenue from Unfair Gouging Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 4317; PBM Reform Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 4570; Interagency Patent Coordination and Improvements Act of 2025 H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program H.R. 6837; To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services oSec. 6702- Full Rebate Pass Through to Plans H.R. 7895; PBM Kickback Prohibition Act H.R. 8143; Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":44250,"prefix":"mr","prefix_display":"MR.","first_name":"JONATHAN","nickname":null,"middle_name":"M","last_name":"HEAFITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143598,"prefix":null,"prefix_display":null,"first_name":"LUCIA","nickname":null,"middle_name":null,"last_name":"LEBENS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147046,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"THREADGILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149676,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"BUSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153596,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MARIN","suffix":null,"suffix_display":null},"covered_position":"Republican Staff Director, House Oversight and Government Reform Committee","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"},{"id":90,"name":"Small Business Administration (SBA)"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S. 526; Pharmacy Benefit Manager Transparency Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3822; Break Up Big Medicine Act H.R. 1244; Reducing Drug Prices for Seniors Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 4317; PBM Reform Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":44250,"prefix":"mr","prefix_display":"MR.","first_name":"JONATHAN","nickname":null,"middle_name":"M","last_name":"HEAFITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143598,"prefix":null,"prefix_display":null,"first_name":"LUCIA","nickname":null,"middle_name":null,"last_name":"LEBENS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147046,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"THREADGILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149676,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"BUSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153596,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MARIN","suffix":null,"suffix_display":null},"covered_position":"Republican Staff Director, House Oversight and Government Reform Committee","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/bf5ee991-09bc-4f67-a9a5-4f23213345fb/","filing_uuid":"bf5ee991-09bc-4f67-a9a5-4f23213345fb","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/bf5ee991-09bc-4f67-a9a5-4f23213345fb/print/","filing_document_content_type":"text/html","income":null,"expenses":"320000.00","expenses_method":"C","expenses_method_display":"C","posted_by_name":"Anne Cassity","dt_posted":"2026-04-20T14:11:20-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"100 DAINGERFIELD ROAD","registrant_address_2":"3rd FLOOR","registrant_different_address":false,"registrant_city":"ALEXANDRIA","registrant_state":"VA","registrant_zip":"22314","registrant":{"id":27478,"url":"https://lda.gov/api/v1/registrants/27478/","house_registrant_id":30354,"name":"NATIONAL COMMUNITY PHARMACISTS ASSOCIATION","description":null,"address_1":"100 DAINGERFIELD ROAD","address_2":"3rd FLOOR","address_3":null,"address_4":null,"city":"ALEXANDRIA","state":"VA","state_display":"Virginia","zip":"22314","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ANNE CASSITY","contact_telephone":"+1 703-683-8200","dt_updated":"2026-07-28T10:07:13.835223-04:00"},"client":{"id":134293,"url":"https://lda.gov/api/v1/clients/134293/","client_id":12,"name":"NATIONAL COMMUNITY PHARMACISTS ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2008-02-13"},"lobbying_activities":[{"general_issue_code":"ALC","general_issue_code_display":"Alcohol and Drug Abuse","description":"Controlled Substances Prescribing & Dispensing; Comments to DOJ & DEA on \"Ensuring Lawful Governance and Implementing the Presidents 'Department of Government Efficiency' Deregulatory Initiative\"; Comments to DEA on \"Special Registrations for Telemedicine and Limited State Telemedicine Registrations [Docket No. DEA-407]\" Comments to DEA on \"Update to DEA Registration Process for Pharmacists to Reflect State Law Changes\"","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63794,"prefix":null,"prefix_display":null,"first_name":"RONNA","nickname":null,"middle_name":null,"last_name":"HAUSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26125,"prefix":null,"prefix_display":null,"first_name":"ANNE","nickname":null,"middle_name":null,"last_name":"CASSITY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142063,"prefix":null,"prefix_display":null,"first_name":"KAITLIN","nickname":null,"middle_name":null,"last_name":"KRELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145270,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":"STEVE","middle_name":"W","last_name":"POSTAL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148025,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"JEREMY","last_name":"WEISSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":37,"name":"Justice, Dept of (DOJ)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"S.891, the Bipartisan Health Care Act; S.882, the Patients Before Middlemen Act; S.927, the Protecting Pharmacies in Medicaid Act; H.R.3164/S.2426, the Ensuring Community Access to Pharmacist Services Act; H.R.2428, the Ensuring Access to Lower-Cost Medicines for Seniors Act; Comments to CMS on the implementation of Medicare Part D Medicare Drug Price Negotiation implementation under the Inflation Reduction Act (IRA; P.L. 117-169); Long-Term Care Pharmacy at Home Services in Medicare; Comments to CMS for its \"Dispensing Entity-CMS Agreement and Dispensing Entity-MTF Data Module Contractor Agreement\" (IRA; P.L.117-169)' H.R.1, the One Big Beautiful Bill Act Comments to CMS on \"Re: Draft Guidance for IPAY 2028 and Manufacturer Effectuation of the MFP for 2026, 2027, and 2028 for the Medicare Drug Price Negotiation Program\"; Comments to CMS on \"Re: Medicare Transaction Facilitator DRAFT Standard Companion Guide Health Care Claim Payment/Advice (835)\" Comments to CMS on \"Re: Agency Information Collection Activities: Proposed Collection; Comment Request [Docket No. CMS-10912] - CMS-10912 Medicare Transaction Facilitator for 2026 and 2027 under Sections 11001 and 11002 of the Inflation Reduction Act (IRA) - Drug Price Negotiation Program MTF DM Dispensing Entity and Third-Party Support Enrollment Form\"; H.Con.Res.14, Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.4317, the PBM Reform Act; H.R.5031/S.3159, the Preserving Patient Access to Long-Term Care Pharmacies Act; Comments to CMS on \"RE:Re: Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model [CMS-1830-P]\"; Comments to CMS on \"Re: Medicare and Medicaid Programs; Calendar Year 2026 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the HH Value-Based Purchasing Expanded Model; Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program Updates; DMEPOS Accreditation Requirements; Provider Enrollment; and Other Medicare and Medicaid Policies [CMS-1828-P]\"; Comments to CMS on \"RE:Re: 340B Program Notice: Application Process for the 340B Rebate Model Pilot Program [HRSA2025 and HRSA-2025-14619]\"; Comments to CMS on \"Re: Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program [CMS-1832-P]\"; H.R.5256, the 340B ACCESS Act; S.2800, the Pharmacy and Medically Underserved Areas Enhancement Act; S.3345, the PBM Price Transparency and Accountability Act; H.R. 6609, Pharmacists Fight Back in Medicare and Medicaid Act; Grassley-Lujan Request-for-Information on Pharmacists Providing Chronic Care; CMMI Potential reimbursement model for CMS coverage of GLP-1 drugs; H.R.7148, the Consolidated Appropriations Act, 2026; Comments to CMS on Proposed Rule \"Re: Medicare Program; Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program\"; Implementation of \"reasonable and relevant\" contract terms in the Medicare Part D Program;","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63794,"prefix":null,"prefix_display":null,"first_name":"RONNA","nickname":null,"middle_name":null,"last_name":"HAUSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26125,"prefix":null,"prefix_display":null,"first_name":"ANNE","nickname":null,"middle_name":null,"last_name":"CASSITY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142063,"prefix":null,"prefix_display":null,"first_name":"KAITLIN","nickname":null,"middle_name":null,"last_name":"KRELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145270,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":"STEVE","middle_name":"W","last_name":"POSTAL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148025,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"JEREMY","last_name":"WEISSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"H.R. 2214, the Delinking Revenue from Unfair Gouging Act; H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.Con.Res 14/S. Con. Res. 7, Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R. 1, the One Big Beautiful Bill; Comments to FDA on \"Re: Agency Information Collection Activities; Proposed Collection; Comment Request; Compounding Animal Drugs From Bulk Drug Substances [Docket No. FDA-2025-N-0082]\"; LHHS Report Language Request to Improve the Care and Treatment of Long-Term Care Residents with Neuropsychiatric Symptoms; Comments to OMB on \"Re: Request for Information: Deregulation\"; Comments to HHS/DOGE on government efficiency, fraud, waste and PBMs; Comments on \"Executive Order 14297 of May 12, 2025 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients\"; Comments to CDC on \"RE: June 25-26 Advisory Committee on Immunization Practices Meeting\"; H.R.5316, the Drug Shortage Compounding and Patient Access Act; H.R.5256, the 340B ACCESS Act; Comments to FDA on \"RE: Docket No. FDA-2025-N-2589, Comments on the Risks and Benefits of Menopause Hormone Therapy\"; H.Res. 805, Recognizing October 2025 as American Pharmacists Month in honor of the contribution of pharmacists to provide safe, accessible, affordable, and beneficial patient care services and products to all residents and protect the public health of our communities; S.3345, the PBM Price Transparency and Accountability Act; H.R. 6609, Pharmacists Fight Back in Medicare and Medicaid Act; H.R. 6610, Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act]; H.R. 6703, the Lower Health Care Premiums for All Americans Act; H.R.5133, the Patient's Right to Know Their Medication Act; H.R. 4409, the Fair Pharmacies for Federal Employees Act; S.3549/H.R.6837, the Fiduciary Accountability, Integrity and Reform (FAIR) Act; H.R.7148, the Consolidated Appropriations Act of 2026; Rural Health Transformation Program; Creation and Implementation of TrumpRx; Comments to FDA on RFI, \"Re: Increasing Access to Nonprescription Drugs; Request for Information\"; S.3822, Break up Big Medicine Act; Comments to FDA on RFT, \"Re: [Docket No. FDA-2025-N-6743] - Scientific and Clinical Considerations for Testosterone Replacement Therapy (TRT) in Men with Hypogonadism\"; Comments to DoL, HHS, and DoT regarding \"Re: Transparency in Coverage Proposed Rule [CMS-9882-P]\"; Pharmacy Shortage Areas in reference to USC-NCPA joint project Mapping Tool; H.R. 7895, the PBM Kickback Prohibition Act; Comments to FDA on their comment request \"Re: Agency Information Collection Activities; Proposed Collection; Comment Request; Medication Guides for Prescription Drug Products [FDA-2025-N-6869]\";","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63794,"prefix":null,"prefix_display":null,"first_name":"RONNA","nickname":null,"middle_name":null,"last_name":"HAUSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26125,"prefix":null,"prefix_display":null,"first_name":"ANNE","nickname":null,"middle_name":null,"last_name":"CASSITY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142063,"prefix":null,"prefix_display":null,"first_name":"KAITLIN","nickname":null,"middle_name":null,"last_name":"KRELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145270,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":"STEVE","middle_name":"W","last_name":"POSTAL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148025,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"JEREMY","last_name":"WEISSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"S.587/1301, The Death Tax Repeal Act;","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63794,"prefix":null,"prefix_display":null,"first_name":"RONNA","nickname":null,"middle_name":null,"last_name":"HAUSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26125,"prefix":null,"prefix_display":null,"first_name":"ANNE","nickname":null,"middle_name":null,"last_name":"CASSITY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142063,"prefix":null,"prefix_display":null,"first_name":"KAITLIN","nickname":null,"middle_name":null,"last_name":"KRELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148025,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"JEREMY","last_name":"WEISSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"LBR","general_issue_code_display":"Labor Issues/Antitrust/Workplace","description":"S.526, the Pharmacy Benefit Manager Transparency Act of 2025; S.527, the Prescription Pricing for the People Act of 2025; Comments to Department of Labor RE: \"Re: Reforming Pharmacy Benefit Manager (PBM) Compensation Practices\";","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63794,"prefix":null,"prefix_display":null,"first_name":"RONNA","nickname":null,"middle_name":null,"last_name":"HAUSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26125,"prefix":null,"prefix_display":null,"first_name":"ANNE","nickname":null,"middle_name":null,"last_name":"CASSITY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142063,"prefix":null,"prefix_display":null,"first_name":"KAITLIN","nickname":null,"middle_name":null,"last_name":"KRELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148025,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"JEREMY","last_name":"WEISSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":64,"name":"Federal Trade Commission (FTC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"TRICARE Pharmacy Network Oversight & Changes; National Defense Authorization Act for Fiscal Year 2026; H.R. 6400/S.4106,the RxACCESS Act;","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63794,"prefix":null,"prefix_display":null,"first_name":"RONNA","nickname":null,"middle_name":null,"last_name":"HAUSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26125,"prefix":null,"prefix_display":null,"first_name":"ANNE","nickname":null,"middle_name":null,"last_name":"CASSITY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142063,"prefix":null,"prefix_display":null,"first_name":"KAITLIN","nickname":null,"middle_name":null,"last_name":"KRELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148025,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"JEREMY","last_name":"WEISSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.Con.Res 14/S. Con. Res. 7, Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.1, the One Big Beautiful Bill Act; H.R.5304, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; H.R.7148, the Consolidated Appropriations Act of 2026;","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63794,"prefix":null,"prefix_display":null,"first_name":"RONNA","nickname":null,"middle_name":null,"last_name":"HAUSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26125,"prefix":null,"prefix_display":null,"first_name":"ANNE","nickname":null,"middle_name":null,"last_name":"CASSITY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142063,"prefix":null,"prefix_display":null,"first_name":"KAITLIN","nickname":null,"middle_name":null,"last_name":"KRELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148025,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"JEREMY","last_name":"WEISSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TEC","general_issue_code_display":"Telecommunications","description":"Comments to HHS on \"HIPAA Security Rule To Strengthen the Cybersecurity of Electronic Protected Health Information [HHS-OCR-0945-AA22]\";","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":26125,"prefix":null,"prefix_display":null,"first_name":"ANNE","nickname":null,"middle_name":null,"last_name":"CASSITY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63794,"prefix":null,"prefix_display":null,"first_name":"RONNA","nickname":null,"middle_name":null,"last_name":"HAUSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142063,"prefix":null,"prefix_display":null,"first_name":"KAITLIN","nickname":null,"middle_name":null,"last_name":"KRELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145270,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":"STEVE","middle_name":"W","last_name":"POSTAL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148025,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"JEREMY","last_name":"WEISSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Comments to CBP on \"June 14, 2024, Internal Advice Letter H283420\"; Comments to on \"Re: Notice of Request for Public Comments on Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients [XRIN 0694- XC120]\";","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63794,"prefix":null,"prefix_display":null,"first_name":"RONNA","nickname":null,"middle_name":null,"last_name":"HAUSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145270,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":"STEVE","middle_name":"W","last_name":"POSTAL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26125,"prefix":null,"prefix_display":null,"first_name":"ANNE","nickname":null,"middle_name":null,"last_name":"CASSITY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":184,"name":"U.S. Customs & Border Protection"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"SMB","general_issue_code_display":"Small Business","description":"Comments to the White House on the Corporate Transparency Act implementations (NDAA; P.L.116-283);","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63794,"prefix":null,"prefix_display":null,"first_name":"RONNA","nickname":null,"middle_name":null,"last_name":"HAUSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145270,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":"STEVE","middle_name":"W","last_name":"POSTAL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26125,"prefix":null,"prefix_display":null,"first_name":"ANNE","nickname":null,"middle_name":null,"last_name":"CASSITY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/1ffec1b7-a7af-4b72-b683-9783c231beb4/","filing_uuid":"1ffec1b7-a7af-4b72-b683-9783c231beb4","filing_type":"1A","filing_type_display":"1st Quarter - Amendment","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/1ffec1b7-a7af-4b72-b683-9783c231beb4/print/","filing_document_content_type":"text/html","income":null,"expenses":"2996995.00","expenses_method":"C","expenses_method_display":"C","posted_by_name":"Jonathan Heafitz","dt_posted":"2026-04-21T12:15:57-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"325 7th Street NW, 9th Floor","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":31348,"url":"https://lda.gov/api/v1/registrants/31348/","house_registrant_id":34004,"name":"PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION","description":"Issues relating to prescription drug benefits","address_1":"325 7th Street NW, 9th Floor","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JONATHAN HEAFITZ","contact_telephone":"+1 202-756-5735","dt_updated":"2026-07-22T16:58:34.643878-04:00"},"client":{"id":138221,"url":"https://lda.gov/api/v1/clients/138221/","client_id":12,"name":"PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION","general_description":"no change","client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-07-01"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"S.1637/H.R 7871; Medicaid VBPs for Patients Act S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S. 2617/H.R. 1244; Reducing Drug Prices for Seniors Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 1041; Affordable Prescriptions for Patients Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3345; PBM Price Transparency and Accountability Act H.R. 4317; PBM Reform Act H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services H.R. 8143; Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":44250,"prefix":"mr","prefix_display":"MR.","first_name":"JONATHAN","nickname":null,"middle_name":"M","last_name":"HEAFITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143598,"prefix":null,"prefix_display":null,"first_name":"LUCIA","nickname":null,"middle_name":null,"last_name":"LEBENS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147046,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"THREADGILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149676,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"BUSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153596,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MARIN","suffix":null,"suffix_display":null},"covered_position":"Republican Staff Director, House Oversight and Government Reform Committee","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S.1637/H.R 7871; Medicaid VBPs for Patients Act S. 2355/H.R. 5582; Patients Deserve Price Tags Act S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S. 526; Pharmacy Benefit Manager Transparency Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 1041; Affordable Prescriptions for Patients Act S. 1095; Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act S. 1096; Preserve Access to Affordable Generics and Biosimilars Act S. 1097; Interagency Patent Coordination and Improvements Act of 2025 S. 1414; Expedited Access to Biosimilars Act S. 2617; Reducing Drug Prices for Seniors Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3345; PBM Price Transparency and Accountability Act S. 3349; PBM Disclosure Act S. 3549; PBM Fiduciary, Accountability, Integrity, and Reform Act S. 3822; Break Up Big Medicine Act H.R. 1244; Reducing Drug Prices for Seniors Act H.R. 2214; Delinking Revenue from Unfair Gouging Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 4317; PBM Reform Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 4570; Interagency Patent Coordination and Improvements Act of 2025 H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program H.R. 6837; To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services oSec. 6702- Full Rebate Pass Through to Plans H.R. 7895; PBM Kickback Prohibition Act H.R. 8143; Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":44250,"prefix":"mr","prefix_display":"MR.","first_name":"JONATHAN","nickname":null,"middle_name":"M","last_name":"HEAFITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143598,"prefix":null,"prefix_display":null,"first_name":"LUCIA","nickname":null,"middle_name":null,"last_name":"LEBENS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147046,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"THREADGILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149676,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"BUSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153596,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MARIN","suffix":null,"suffix_display":null},"covered_position":"Republican Staff Director, House Oversight and Government Reform Committee","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"},{"id":90,"name":"Small Business Administration (SBA)"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S. 526; Pharmacy Benefit Manager Transparency Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3822; Break Up Big Medicine Act H.R. 1244; Reducing Drug Prices for Seniors Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 4317; PBM Reform Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":44250,"prefix":"mr","prefix_display":"MR.","first_name":"JONATHAN","nickname":null,"middle_name":"M","last_name":"HEAFITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143598,"prefix":null,"prefix_display":null,"first_name":"LUCIA","nickname":null,"middle_name":null,"last_name":"LEBENS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147046,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"THREADGILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149676,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"BUSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153596,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MARIN","suffix":null,"suffix_display":null},"covered_position":"Republican Staff Director, House Oversight and Government Reform Committee","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/ffa88e50-9459-4df5-a323-7360719ad7ae/","filing_uuid":"ffa88e50-9459-4df5-a323-7360719ad7ae","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/ffa88e50-9459-4df5-a323-7360719ad7ae/print/","filing_document_content_type":"text/html","income":null,"expenses":"70000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Scott Frey","dt_posted":"2026-07-16T20:52:48-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2033 K Street NW","registrant_address_2":"Suite 450","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":401010854,"url":"https://lda.gov/api/v1/registrants/401010854/","house_registrant_id":42171,"name":"ALLIANCE FOR AGING RESEARCH","description":"Non-profit healthcare advocacy organization","address_1":"2033 K Street NW","address_2":"Suite 450","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"SCOTT FREY","contact_telephone":"+1 571-289-1385","dt_updated":"2026-09-24T12:38:43.419803-04:00"},"client":{"id":196811,"url":"https://lda.gov/api/v1/clients/196811/","client_id":12,"name":"ALLIANCE FOR AGING RESEARCH","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2015-05-04"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"-Alzheimer's Screening & Prevention Act (ASAP) H.R. 6130/ S. 3267 -Lowering Costs for Caregivers Act (S. 1565/H.R. 138) -Federal vaccine messaging -Impacts of IRA on Older Americans -National Institutes of Health advance funding of multi-year research grants -Clinical Trials Modernization Act H.R.7905 -Patient Access to Cancer and Complex Therapies Act H.R. 4299 -Diabetes Foot Health and Modernization Access Act H.R. 7905 -Oppose PBM Kickbacks H.R. 7895 -Oppose Codification of MFN Drug Pricing Proposals (no bill) -Message support for Rare Disease Clinical Trials Improvements","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138576,"prefix":"ms","prefix_display":"MS.","first_name":"ADINA","nickname":null,"middle_name":"ROSE","last_name":"LASSER","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":149533,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"FREY","suffix":null,"suffix_display":null},"covered_position":"Deputy Commissioner for Legislation and Congressional Affairs -- SSA, Chief of Staff -- SSA, Senior Strategic Advisor -- Office of National Drug Control Policy","new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"-Implementation of Medicare Part D beneficiary affordability provisions -Nursing home quality measures -Implementation of the Medicare Direct Negotiation Program and its impact on older adults -Utilization management reform in Medicare -Increasing Medication Access for Seniors Act (H.R.6401)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138576,"prefix":"ms","prefix_display":"MS.","first_name":"ADINA","nickname":null,"middle_name":"ROSE","last_name":"LASSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149533,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"FREY","suffix":null,"suffix_display":null},"covered_position":"Deputy Commissioner for Legislation and Congressional Affairs -- SSA, Chief of Staff -- SSA, Senior Strategic Advisor -- Office of National Drug Control Policy","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"-FY27 report language for the Food and Drug Administration on antipsychotics black box warning -FY27 report language for the Medicare Program antipsychotics measure -FY27 report language for the Medicare Prescription Payment Plan -FY27 report language for utilization management reform in the Medicare program -FY27 medical research funding -FY27 funding for FDA's Neurology Drug Program -FY 27 Appropriations H.R. 9260 and pending Senate bill, Increase Funding for Programs benefitting older adults at HHS, including ASPE, NIH, CDC HRSA, ARHQ, FDA, CMS, ACL","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138576,"prefix":"ms","prefix_display":"MS.","first_name":"ADINA","nickname":null,"middle_name":"ROSE","last_name":"LASSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149533,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"FREY","suffix":null,"suffix_display":null},"covered_position":"Deputy Commissioner for Legislation and Congressional Affairs -- SSA, Chief of Staff -- SSA, Senior Strategic Advisor -- Office of National Drug Control Policy","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/cd8cbe49-569a-4b7a-b4d9-35a57eafeba2/","filing_uuid":"cd8cbe49-569a-4b7a-b4d9-35a57eafeba2","filing_type":"2A","filing_type_display":"2nd Quarter - Amendment","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/cd8cbe49-569a-4b7a-b4d9-35a57eafeba2/print/","filing_document_content_type":"text/html","income":null,"expenses":"70000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Scott Frey","dt_posted":"2026-07-16T21:11:28-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2033 K Street NW","registrant_address_2":"Suite 450","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":401010854,"url":"https://lda.gov/api/v1/registrants/401010854/","house_registrant_id":42171,"name":"ALLIANCE FOR AGING RESEARCH","description":"Non-profit healthcare advocacy organization","address_1":"2033 K Street NW","address_2":"Suite 450","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"SCOTT FREY","contact_telephone":"+1 571-289-1385","dt_updated":"2026-09-24T12:38:43.419803-04:00"},"client":{"id":196811,"url":"https://lda.gov/api/v1/clients/196811/","client_id":12,"name":"ALLIANCE FOR AGING RESEARCH","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2015-05-04"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"-FY27 report language for the Food and Drug Administration on antipsychotics black box warning -FY27 report language for the Medicare Program antipsychotics measure -FY27 report language for the Medicare Prescription Payment Plan -FY27 report language for utilization management reform in the Medicare program -FY27 medical research funding -FY27 funding for FDA's Neurology Drug Program -FY 27 Appropriations H.R. 9260 and pending Senate bill, Increase Funding for Programs benefitting older adults at HHS, including ASPE, NIH, CDC HRSA, ARHQ, FDA, CMS, ACL","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138576,"prefix":"ms","prefix_display":"MS.","first_name":"ADINA","nickname":null,"middle_name":"ROSE","last_name":"LASSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149533,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"FREY","suffix":null,"suffix_display":null},"covered_position":"Deputy Commissioner for Legislation and Congressional Affairs -- SSA, Chief of Staff -- SSA, Senior Strategic Advisor -- Office of National Drug Control Policy","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"-Alzheimer's Screening & Prevention Act (ASAP) H.R. 6130/ S. 3267 -Lowering Costs for Caregivers Act (S. 1565/H.R. 138) -Federal vaccine messaging -Impacts of IRA on Older Americans -National Institutes of Health advance funding of multi-year research grants -Clinical Trials Modernization Act H.R.7905 -Patient Access to Cancer and Complex Therapies Act H.R. 4299 -Diabetes Foot Health and Modernization Access Act H.R. 7905 -Oppose PBM Kickbacks H.R. 7895 -Oppose Codification of MFN Drug Pricing Proposals (no bill) -End Coverage with Evidence Development for Alzheimer's medications and Trans Catheter Aortic Valve Replacement","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138576,"prefix":"ms","prefix_display":"MS.","first_name":"ADINA","nickname":null,"middle_name":"ROSE","last_name":"LASSER","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":149533,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"FREY","suffix":null,"suffix_display":null},"covered_position":"Deputy Commissioner for Legislation and Congressional Affairs -- SSA, Chief of Staff -- SSA, Senior Strategic Advisor -- Office of National Drug Control Policy","new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"-Implementation of Medicare Part D beneficiary affordability provisions -Nursing home quality measures -Implementation of the Medicare Direct Negotiation Program and its impact on older adults -Utilization management reform in Medicare -Increasing Medication Access for Seniors Act (H.R.6401) -End Coverage with Evidence Development for Alzheimer's Medications and TAVR","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138576,"prefix":"ms","prefix_display":"MS.","first_name":"ADINA","nickname":null,"middle_name":"ROSE","last_name":"LASSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149533,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"FREY","suffix":null,"suffix_display":null},"covered_position":"Deputy Commissioner for Legislation and Congressional Affairs -- SSA, Chief of Staff -- SSA, Senior Strategic Advisor -- Office of National Drug Control Policy","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/f56204c1-6861-47d1-9f11-04dfdeb74295/","filing_uuid":"f56204c1-6861-47d1-9f11-04dfdeb74295","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/f56204c1-6861-47d1-9f11-04dfdeb74295/print/","filing_document_content_type":"text/html","income":null,"expenses":"270000.00","expenses_method":"C","expenses_method_display":"C","posted_by_name":"Anne Cassity","dt_posted":"2026-07-17T16:11:03-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"100 DAINGERFIELD ROAD","registrant_address_2":"3rd FLOOR","registrant_different_address":false,"registrant_city":"ALEXANDRIA","registrant_state":"VA","registrant_zip":"22314","registrant":{"id":27478,"url":"https://lda.gov/api/v1/registrants/27478/","house_registrant_id":30354,"name":"NATIONAL COMMUNITY PHARMACISTS ASSOCIATION","description":null,"address_1":"100 DAINGERFIELD ROAD","address_2":"3rd FLOOR","address_3":null,"address_4":null,"city":"ALEXANDRIA","state":"VA","state_display":"Virginia","zip":"22314","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ANNE CASSITY","contact_telephone":"+1 703-683-8200","dt_updated":"2026-07-28T10:07:13.835223-04:00"},"client":{"id":134293,"url":"https://lda.gov/api/v1/clients/134293/","client_id":12,"name":"NATIONAL COMMUNITY PHARMACISTS ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2008-02-13"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"S.891, the Bipartisan Health Care Act; S.882, the Patients Before Middlemen Act; S.927, the Protecting Pharmacies in Medicaid Act; H.R.3164/S.2426, the Mainstreet Pharmacy Access Act/the Ensuring Community Access to Pharmacist Services Act; H.R.2428, the Ensuring Access to Lower-Cost Medicines for Seniors Act; Comments to CMS on the implementation of Medicare Part D Medicare Drug Price Negotiation implementation under the Inflation Reduction Act (IRA; P.L. 117-169); Long-Term Care Pharmacy at Home Services in Medicare; Comments to CMS for its \"Dispensing Entity-CMS Agreement and Dispensing Entity-MTF Data Module Contractor Agreement\" (IRA; P.L.117-169)' H.R.1, the One Big Beautiful Bill Act Comments to CMS on \"Re: Draft Guidance for IPAY 2028 and Manufacturer Effectuation of the MFP for 2026, 2027, and 2028 for the Medicare Drug Price Negotiation Program\"; Comments to CMS on \"Re: Medicare Transaction Facilitator DRAFT Standard Companion Guide Health Care Claim Payment/Advice (835)\" Comments to CMS on \"Re: Agency Information Collection Activities: Proposed Collection; Comment Request [Docket No. CMS-10912] - CMS-10912 Medicare Transaction Facilitator for 2026 and 2027 under Sections 11001 and 11002 of the Inflation Reduction Act (IRA) - Drug Price Negotiation Program MTF DM Dispensing Entity and Third-Party Support Enrollment Form\"; H.Con.Res.14, Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.4317, the PBM Reform Act; H.R.5031/S.3159, the Preserving Patient Access to Long-Term Care Pharmacies Act; Comments to CMS on \"RE:Re: Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model [CMS-1830-P]\"; Comments to CMS on \"Re: Medicare and Medicaid Programs; Calendar Year 2026 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the HH Value-Based Purchasing Expanded Model; Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program Updates; DMEPOS Accreditation Requirements; Provider Enrollment; and Other Medicare and Medicaid Policies [CMS-1828-P]\"; Comments to CMS on \"RE:Re: 340B Program Notice: Application Process for the 340B Rebate Model Pilot Program [HRSA2025 and HRSA-2025-14619]\"; Comments to CMS on \"Re: Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program [CMS-1832-P]\"; H.R.5256, the 340B ACCESS Act; S.2800, the Pharmacy and Medically Underserved Areas Enhancement Act; S.3345, the PBM Price Transparency and Accountability Act; H.R. 6609, Pharmacists Fight Back in Medicare and Medicaid Act; Grassley-Lujan Request-for-Information on Pharmacists Providing Chronic Care; CMMI Potential reimbursement model for CMS coverage of GLP-1 drugs; H.R.7148, the Consolidated Appropriations Act, 2026; Comments to CMS on Proposed Rule \"Re: Medicare Program; Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program\"; Implementation of \"reasonable and relevant\" contract terms in the Medicare Part D Program; Comments to CMS on \"Re: Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; Interoperability Standards and Prior Authorization for Drugs for Medicare Advantage Organizations, Medicaid Managed Care Plans, State Medicaid Agencies, Childrens Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, and Issuers of Qualified Health Plans on the Federally-Facilitated Exchanges [CMS-0062-P]\"; Comments to CMS on \"Re: Medicare GLP-1 Bridge Program - Improper Restriction of the $5.00 LTC Dispensing Fee to Nursing Facility and ICF/IID Residents; Conflict with 42 C.F.R. 423.120, Chapter 5, Section 20.7 of the Medicare Prescription Drug Benefit Manual, and CMSs December 15, 2021 Guidance on LTC Pharmacy Access\";","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63794,"prefix":null,"prefix_display":null,"first_name":"RONNA","nickname":null,"middle_name":null,"last_name":"HAUSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26125,"prefix":null,"prefix_display":null,"first_name":"ANNE","nickname":null,"middle_name":null,"last_name":"CASSITY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142063,"prefix":null,"prefix_display":null,"first_name":"KAITLIN","nickname":null,"middle_name":null,"last_name":"KRELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145270,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":"STEVE","middle_name":"W","last_name":"POSTAL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148025,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"JEREMY","last_name":"WEISSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"H.R. 2214, the Delinking Revenue from Unfair Gouging Act; H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.Con.Res 14/S. Con. Res. 7, Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R. 1, the One Big Beautiful Bill; Comments to FDA on \"Re: Agency Information Collection Activities; Proposed Collection; Comment Request; Compounding Animal Drugs From Bulk Drug Substances [Docket No. FDA-2025-N-0082]\"; LHHS Report Language Request to Improve the Care and Treatment of Long-Term Care Residents with Neuropsychiatric Symptoms; Comments to OMB on \"Re: Request for Information: Deregulation\"; Comments to HHS/DOGE on government efficiency, fraud, waste and PBMs; Comments on \"Executive Order 14297 of May 12, 2025 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients\"; Comments to CDC on \"RE: June 25-26 Advisory Committee on Immunization Practices Meeting\"; H.R.5316, the Drug Shortage Compounding and Patient Access Act; H.R.5256, the 340B ACCESS Act; Comments to FDA on \"RE: Docket No. FDA-2025-N-2589, Comments on the Risks and Benefits of Menopause Hormone Therapy\"; H.Res. 805, Recognizing October 2025 as American Pharmacists Month in honor of the contribution of pharmacists to provide safe, accessible, affordable, and beneficial patient care services and products to all residents and protect the public health of our communities; S.3345, the PBM Price Transparency and Accountability Act; H.R. 6609, Pharmacists Fight Back in Medicare and Medicaid Act; H.R. 6610, Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act]; H.R. 6703, the Lower Health Care Premiums for All Americans Act; H.R.5133, the Patient's Right to Know Their Medication Act; H.R. 4409, the Fair Pharmacies for Federal Employees Act; S.3549/H.R.6837, the Fiduciary Accountability, Integrity and Reform (FAIR) Act; H.R.7148, the Consolidated Appropriations Act of 2026; Rural Health Transformation Program; Creation and Implementation of TrumpRx; Comments to FDA on RFI, \"Re: Increasing Access to Nonprescription Drugs; Request for Information\"; S.3822, Break up Big Medicine Act; Comments to FDA on RFT, \"Re: [Docket No. FDA-2025-N-6743] - Scientific and Clinical Considerations for Testosterone Replacement Therapy (TRT) in Men with Hypogonadism\"; Comments to DoL, HHS, and DoT regarding \"Re: Transparency in Coverage Proposed Rule [CMS-9882-P]\"; Pharmacy Shortage Areas in reference to USC-NCPA joint project Mapping Tool; H.R. 7895, the PBM Kickback Prohibition Act; Comments to FDA on their comment request \"Re: Agency Information Collection Activities; Proposed Collection; Comment Request; Medication Guides for Prescription Drug Products [FDA-2025-N-6869]\"; H.R.6509/S.3794, the SAFE Drug Act; H.R.5316, the Drug Shortage Compounding Patient Access Act; H.R.8779/S.4509, the Patients Before Monopolies Act; S.3788/H.R.8269, the CLEAR LABELS Act; S.1941, the Cure Hepatitis C Act of 2025;","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63794,"prefix":null,"prefix_display":null,"first_name":"RONNA","nickname":null,"middle_name":null,"last_name":"HAUSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26125,"prefix":null,"prefix_display":null,"first_name":"ANNE","nickname":null,"middle_name":null,"last_name":"CASSITY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142063,"prefix":null,"prefix_display":null,"first_name":"KAITLIN","nickname":null,"middle_name":null,"last_name":"KRELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145270,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":"STEVE","middle_name":"W","last_name":"POSTAL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148025,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"JEREMY","last_name":"WEISSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":40,"name":"Transportation, Dept of (DOT)"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"S.587/1301, The Death Tax Repeal Act;","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63794,"prefix":null,"prefix_display":null,"first_name":"RONNA","nickname":null,"middle_name":null,"last_name":"HAUSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26125,"prefix":null,"prefix_display":null,"first_name":"ANNE","nickname":null,"middle_name":null,"last_name":"CASSITY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142063,"prefix":null,"prefix_display":null,"first_name":"KAITLIN","nickname":null,"middle_name":null,"last_name":"KRELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148025,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"JEREMY","last_name":"WEISSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"ALC","general_issue_code_display":"Alcohol and Drug Abuse","description":"Controlled Substances Prescribing & Dispensing; Comments to DOJ & DEA on \"Ensuring Lawful Governance and Implementing the Presidents 'Department of Government Efficiency' Deregulatory Initiative\"; Comments to DEA on \"Special Registrations for Telemedicine and Limited State Telemedicine Registrations [Docket No. DEA-407]\" Comments to DEA on \"Update to DEA Registration Process for Pharmacists to Reflect State Law Changes\"","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63794,"prefix":null,"prefix_display":null,"first_name":"RONNA","nickname":null,"middle_name":null,"last_name":"HAUSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26125,"prefix":null,"prefix_display":null,"first_name":"ANNE","nickname":null,"middle_name":null,"last_name":"CASSITY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142063,"prefix":null,"prefix_display":null,"first_name":"KAITLIN","nickname":null,"middle_name":null,"last_name":"KRELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145270,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":"STEVE","middle_name":"W","last_name":"POSTAL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148025,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"JEREMY","last_name":"WEISSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":37,"name":"Justice, Dept of (DOJ)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LBR","general_issue_code_display":"Labor Issues/Antitrust/Workplace","description":"S.526, the Pharmacy Benefit Manager Transparency Act of 2025; S.527, the Prescription Pricing for the People Act of 2025; Comments to Department of Labor RE: \"Re: Reforming Pharmacy Benefit Manager (PBM) Compensation Practices\"; H.R.7895, the PBM Kickback Prohibition Act; Comments to DOL on \"Re: Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure [RIN 1210-AB37]\"' Comments to DOJ on \"Re: NCPA Comment on Competitor Collaboration Guidance (Docket No. ATR-2026- 0001)\"' H.R.8779/S.4509, the Patients Before Monopolies Act;","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63794,"prefix":null,"prefix_display":null,"first_name":"RONNA","nickname":null,"middle_name":null,"last_name":"HAUSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26125,"prefix":null,"prefix_display":null,"first_name":"ANNE","nickname":null,"middle_name":null,"last_name":"CASSITY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142063,"prefix":null,"prefix_display":null,"first_name":"KAITLIN","nickname":null,"middle_name":null,"last_name":"KRELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148025,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"JEREMY","last_name":"WEISSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":64,"name":"Federal Trade Commission (FTC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"TRICARE Pharmacy Network Oversight & Changes; H.R.8800/S.4784, the National Defense Authorization Act for Fiscal Year 2027; H.R. 6400/S.4106,the RxACCESS Act;","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63794,"prefix":null,"prefix_display":null,"first_name":"RONNA","nickname":null,"middle_name":null,"last_name":"HAUSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26125,"prefix":null,"prefix_display":null,"first_name":"ANNE","nickname":null,"middle_name":null,"last_name":"CASSITY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142063,"prefix":null,"prefix_display":null,"first_name":"KAITLIN","nickname":null,"middle_name":null,"last_name":"KRELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148025,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"JEREMY","last_name":"WEISSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.Con.Res 14/S. Con. Res. 7, Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.1, the One Big Beautiful Bill Act; H.R.5304, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; H.R.7148, the Consolidated Appropriations Act of 2026;","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63794,"prefix":null,"prefix_display":null,"first_name":"RONNA","nickname":null,"middle_name":null,"last_name":"HAUSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26125,"prefix":null,"prefix_display":null,"first_name":"ANNE","nickname":null,"middle_name":null,"last_name":"CASSITY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142063,"prefix":null,"prefix_display":null,"first_name":"KAITLIN","nickname":null,"middle_name":null,"last_name":"KRELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148025,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"JEREMY","last_name":"WEISSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TEC","general_issue_code_display":"Telecommunications","description":"Comments to HHS on \"HIPAA Security Rule To Strengthen the Cybersecurity of Electronic Protected Health Information [HHS-OCR-0945-AA22]\";","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":26125,"prefix":null,"prefix_display":null,"first_name":"ANNE","nickname":null,"middle_name":null,"last_name":"CASSITY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63794,"prefix":null,"prefix_display":null,"first_name":"RONNA","nickname":null,"middle_name":null,"last_name":"HAUSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142063,"prefix":null,"prefix_display":null,"first_name":"KAITLIN","nickname":null,"middle_name":null,"last_name":"KRELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145270,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":"STEVE","middle_name":"W","last_name":"POSTAL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148025,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"JEREMY","last_name":"WEISSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Comments to CBP on \"June 14, 2024, Internal Advice Letter H283420\"; Comments to on \"Re: Notice of Request for Public Comments on Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients [XRIN 0694- XC120]\";","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63794,"prefix":null,"prefix_display":null,"first_name":"RONNA","nickname":null,"middle_name":null,"last_name":"HAUSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145270,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":"STEVE","middle_name":"W","last_name":"POSTAL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26125,"prefix":null,"prefix_display":null,"first_name":"ANNE","nickname":null,"middle_name":null,"last_name":"CASSITY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":184,"name":"U.S. Customs & Border Protection"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"SMB","general_issue_code_display":"Small Business","description":"Comments to the White House on the Corporate Transparency Act implementations (NDAA; P.L.116-283); Comments to Treasury on the Corporate Transparency Act implementations (NDAA; P.L.116-283);","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63794,"prefix":null,"prefix_display":null,"first_name":"RONNA","nickname":null,"middle_name":null,"last_name":"HAUSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145270,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":"STEVE","middle_name":"W","last_name":"POSTAL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26125,"prefix":null,"prefix_display":null,"first_name":"ANNE","nickname":null,"middle_name":null,"last_name":"CASSITY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":41,"name":"Treasury, Dept of"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/67733c57-53d2-47d4-8062-3d10d420c0ac/","filing_uuid":"67733c57-53d2-47d4-8062-3d10d420c0ac","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/67733c57-53d2-47d4-8062-3d10d420c0ac/print/","filing_document_content_type":"text/html","income":null,"expenses":"1670000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Adam Temple","dt_posted":"2026-07-20T11:27:19-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"555 12th Street NW","registrant_address_2":"Suite 1001","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":27811,"url":"https://lda.gov/api/v1/registrants/27811/","house_registrant_id":30604,"name":"NFIB (NATIONAL FEDERATION OF INDEPENDENT BUSINESS)","description":"Lobbying on behalf of small business","address_1":"555 12th Street NW","address_2":"Suite 1001","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ADAM TEMPLE","contact_telephone":"+1 423-509-7989","dt_updated":"2026-07-30T16:06:39.961905-04:00"},"client":{"id":134461,"url":"https://lda.gov/api/v1/clients/134461/","client_id":12,"name":"NFIB (NATIONAL FEDERATION OF INDEPENDENT BUSINESS)","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2012-11-05"},"lobbying_activities":[{"general_issue_code":"SMB","general_issue_code_display":"Small Business","description":"House: H.R.1, An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14. H.R. 425, the Repealing Big Brother Overreach Act H.R.7035, the Credit Card Competition Act of 2026 H.R. 6213, the Heat Workforce Standards Act of 2025 H.R. 4776, the Standardizing Permitting and Expediting Economic Development (SPEED) Act H.R. 4366, the Save Local Business Act H.R. 3898, the Promoting Efficient Review for Modern Infrastructure Today (PERMIT) Act H.R. 3699, the Energy Choice Act H.R. 4424, the Securing Help for Involuntary Employment Loss and Displacement (SHIELD) Act H.R. 5463, the Custom Health Option and Individual Care Expense (CHOICE) Arrangement Act H.R.6703, the Lower Health Care Premiums for All Americans Act H.R. 20, the Richard L. Trumka Protecting the Right to Organize (PRO) Act H.R. 4896, the Warehouse Worker Protection Act H.R. 2743, the Raise the Wage Act H.R. 1319, the Modern Worker Empowerment Act H.R. 1566, the Right to Equitable and Professional Auto Industry Repair (REPAIR) Act H.R. 5349, the Tax Court Improvement Act H.R. 5346, the Fair and Accountable IRS Review Act H.R.5267, the American Franchise Act H.R. 2528, the Association Health Plans Act H.R. 6420, the Affordable Care Economic Stability and Small Business (ACCESS) Act H.R.1163, the Prove It Act of 2025 H.R. 5258, the Lawsuit Abuse Reduction Act of 2025 H.R. 2675, the Protecting Our Courts from Foreign Manipulation Act of 2025 H.R. 4626, the Home Appliance Protection and Affordability Act H.R.7148 - Consolidated Appropriations Act, 2026 H.R.7328 - Protecting Small Businesses from Predatory Website Lawsuits Act H.R. 6250, the Cold Weather Diesel Reliability Act of 2025 H.R. 6453, the Americans with Disabilities Act 30 Days to Comply Act H.R.7847, the Stop Unemployment Fraud Act H.R. 2528, the Association Health Plans Act H.R. 8082, the Competition and Openness in Markets to Promote Efficiency, Transparency, and Enhanced Affordability (COMPETE) Act H.R. 6538, the More Affordable Care Act H.R. 5582, the Patients Deserve Price Tags Act H.R. 5408, the Faster Labor Contracts Act H.R.8800, National Defense Authorization Act for Fiscal Year 2027 H.R.3269, Eliminating Thickets to Increase Competition (ETHIC) Act H.R. 5337, Motor Carrier Safety Selection Standard Act Consumer Financial Protection Bureau Section 1071 rule requires covered financial institutions to collect and report demographic and credit data on small business loan applications. H.R. 8415, Small Business Tax Cut Act H.R. 1897, Endangered Species (ES) Amendments Act of 2025 H.R.5166, Financial Services and General Government Appropriations Act, 2026 H.R. 1687, the Committing Leases for Energy Access Now (CLEAN) Act H.R. 6398, the Reducing and Eliminating Duplicative Environmental Regulations Act H.R. 8414, Know Your Labor Rights Act H.R. 8415, Small Business Tax Cuts Act of 2026 H.R. 7861, HSAs for All Act H.R. 7895, PBM Kickback Prohibition Act Issues relating to small business taxation Issues related to the expiring TCJA tax provisions Issues related to ADA website reforms Issues related to the minimum wage increase Issues related to \"Affordable Care Act Reform\" Issues related to Pharmacy Benefit Managers Issues related to Health Reform Issues related to regulatory reforms Senate: S. 100, the Repealing Big Brother Overreach Act S.3623, the Credit Card Competition Act of 2026 S. 4427, Heat Workforce Standards Act of 2026 S. 3117, the Worker Reforming Elections for Speedy and Unimpeded Labor Talks (RESULTS) Act S. 3116, the Fairness in Filing Act S. 5213, the Union Members' Right to Know Act S.3124, the Protection on the Picket Line Act S.3128, the Worker Privacy Act S. 852, the Richard L. Trumka Protecting the Right to Organize (PRO) Act S. 2613, the Warehouse Worker Protection Act S. 844, the Faster Labor Contracts Act S. 2013, the Higher Wages for American Workers Act S. 1332, the Raise the Wage Act S. 1945, the Energy Choice Act S. 1379, the Right to Equitable and Professional Auto Industry Repair (REPAIR) Act S.2875, the Custom Health Option and Individual Care Expense (CHOICE) Act S. 1847, the Association Health Plans Act S. 3418, the Competition and Openness in Markets to Promote Efficiency, Transparency, and Enhanced Affordability (COMPETE) Act S.495, Prove it Act of 2025 S. 3264, the More Affordable Care Act S. 2355, the Patients Deserve Price Tags Act S. 4366, Know Your Labor Rights Act S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act S. 4419: A bill to amend title 31, United States Code, to require only foreign entities to report beneficial ownership information, and for other purposes. Issue relating to small business taxation Issue related to the expiring TCJA tax provisions Issue related to ADA website reforms Issue related to the minimum wage increase Issue related to \"Affordable Care Act Reform\" Issue related to Pharmacy Benefits Managers Department of the Treasury: Beneficial Ownership Information (BOI) Reporting Rule H.R.1, An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14. White House: Beneficial Ownership Information (BOI) Reporting Rule Heat Injury and Illness Prevention in Outdoor and Indoor Work Settings Rule Issues relating to the right to repair Office of Management and Budget: Beneficial Ownership Information (BOI) Reporting Rule H.R.7035/S.3623, the Credit Card Competition Act of 2026 H.R. 1566/S. 1379, the Right to Equitable and Professional Auto Industry Repair (REPAIR) Act Heat Injury and Illness Prevention in Outdoor and Indoor Work Settings Rule Issues related to Short-Term Limited Duration Insurance Plans Financial Crimes Enforcement Network: Beneficial Ownership Information (BOI) Reporting Rule Department of Health and Human Services: Issues related to Individual Coverage Health Reimbursement Arrangements (ICHRA) Regulation Reform Department of Labor: Heat Injury and Illness Prevention in Outdoor and Indoor Work Settings Rule Issues related to General Health Care Reform Occupational Safety and Health Administration: Heat Injury and Illness Prevention in Outdoor and Indoor Work Settings Rule","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":17374,"prefix":null,"prefix_display":null,"first_name":"BRAD","nickname":null,"middle_name":null,"last_name":"CLOSE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145069,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"TEMPLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141297,"prefix":null,"prefix_display":null,"first_name":"JOSHUA","nickname":null,"middle_name":null,"last_name":"MCLEOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146938,"prefix":null,"prefix_display":null,"first_name":"DYLAN","nickname":null,"middle_name":null,"last_name":"ROSNICK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149442,"prefix":null,"prefix_display":null,"first_name":"TYLER","nickname":null,"middle_name":null,"last_name":"DEVER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151220,"prefix":"mr","prefix_display":"MR.","first_name":"TIMOTHY","nickname":null,"middle_name":"RYAN","last_name":"NUNGESSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151564,"prefix":null,"prefix_display":null,"first_name":"LOUIS","nickname":null,"middle_name":null,"last_name":"BERTOLOTTI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153661,"prefix":null,"prefix_display":null,"first_name":"MARY","nickname":null,"middle_name":"ALEX","last_name":"HAMBY","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":235,"name":"Financial Crimes Enforcement Network (FinCEN)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":167,"name":"Occupational Safety & Health Administration (OSHA)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/31eede6b-60a7-462a-a4db-1e34d8e1a67e/","filing_uuid":"31eede6b-60a7-462a-a4db-1e34d8e1a67e","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/31eede6b-60a7-462a-a4db-1e34d8e1a67e/print/","filing_document_content_type":"text/html","income":null,"expenses":"700000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Alison Esquea","dt_posted":"2026-07-20T11:54:27-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"700 12th St NW","registrant_address_2":"Ste. 700","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":401105208,"url":"https://lda.gov/api/v1/registrants/401105208/","house_registrant_id":null,"name":"CAMBIA HEALTH SOLUTIONS","description":"Innovative health care solutions","address_1":"601 13th St. NW, Ste. 900 South","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ALISON ESQUEA","contact_telephone":"+1 202-253-5455","dt_updated":"2026-07-27T16:33:38.902734-04:00"},"client":{"id":203401,"url":"https://lda.gov/api/v1/clients/203401/","client_id":12,"name":"CAMBIA HEALTH SOLUTIONS","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-02-19"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Affordable Care Act and Extending Enhanced APTCs (H.R. 247; S. 46), 2026 Proposed NBPP/Individual Market/ACA exchanges; Fraudulent Enrollments in Qualified Health Plans (S. 976, HR 2079), Behavioral Health, Employer-Provided Health Coverage; Surprise Billing (S. 2420, H.R. 4710); Cybersecurity; Health IT, Health Care Innovation, Transparency & PBMs (S. 891, H.R. 6703), PBM Compensation (H.R. 7895), Prescription Drugs (S. 1954, S. 1096, S. 1096, S.1040) Price Transparency (S. 2355, H.R. 9393, H.R. 9397), Prior Authorization (H.R. 9396), 340B.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70189,"prefix":null,"prefix_display":null,"first_name":"ALISON","nickname":null,"middle_name":null,"last_name":"ESQUEA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145155,"prefix":null,"prefix_display":null,"first_name":"RYNE","nickname":null,"middle_name":null,"last_name":"CARNEY","suffix":null,"suffix_display":null},"covered_position":"Intern - Rep. Ed Perlmutter","new":false},{"lobbyist":{"id":153403,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"HRUBY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Medicare Advantage: Star Ratings, Risk Adjustment, Supplemental Benefits (H.R. 5746, H.R. 5243), No UPCODE Act (S. 1105), Medicare Prior Authorization and Electronic Prior Authorization (H.R. 3514, H.R. 8375), Provider Directories (S. 891), Telehealth Extending Flexibilities (H.R. 4206, S. 1261), Transparency & PBMs (S. 882; S. 891, S. 3345), Physician Fee Schedule, Site Neutrality (H.R. 7149, H.R. 3417 from 118th), Broker/Agents (H.R. 9395).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70189,"prefix":null,"prefix_display":null,"first_name":"ALISON","nickname":null,"middle_name":null,"last_name":"ESQUEA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145155,"prefix":null,"prefix_display":null,"first_name":"RYNE","nickname":null,"middle_name":null,"last_name":"CARNEY","suffix":null,"suffix_display":null},"covered_position":"Intern - Rep. Ed Perlmutter","new":false},{"lobbyist":{"id":153403,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"HRUBY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/26fbda3a-a50c-4418-b664-a6de4a0e1c4a/","filing_uuid":"26fbda3a-a50c-4418-b664-a6de4a0e1c4a","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/26fbda3a-a50c-4418-b664-a6de4a0e1c4a/print/","filing_document_content_type":"text/html","income":"270000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Chatrane Birbal","dt_posted":"2026-07-20T14:47:21-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"4201 Wilson Blvd","registrant_address_2":"Ste 110-368","registrant_different_address":false,"registrant_city":"Arlington","registrant_state":"VA","registrant_zip":"22203","registrant":{"id":319756,"url":"https://lda.gov/api/v1/registrants/319756/","house_registrant_id":39477,"name":"TRIBUTARY LLP","description":"Law Firm","address_1":"4201 Wilson Blvd","address_2":"Ste 110-368","address_3":null,"address_4":null,"city":"Arlington","state":"VA","state_display":"Virginia","zip":"22203","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CHATRANE BIRBAL","contact_telephone":"+1 202-375-5011","dt_updated":"2026-07-22T11:21:31.040500-04:00"},"client":{"id":186504,"url":"https://lda.gov/api/v1/clients/186504/","client_id":48,"name":"CHRO ASSOCIATION (FKA HR POLICY ASSOCIATION)","general_description":null,"client_government_entity":false,"client_self_select":null,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2008-02-12"},"lobbying_activities":[{"general_issue_code":"LBR","general_issue_code_display":"Labor Issues/Antitrust/Workplace","description":"4/15 - House Education and Workforce Hearing on AI Implementation 4/16 - Letter in opposition to Prioritizing the Warfighter in Defense Contracting Act of 2026 (S. 4212) 4/29- CHRO Association Opposition to the Faster Labor Contracts Act 5/1- Labor Court Proposal re National Labor Relations Board 6/26- Stock Buyback Prohibitions / Amendment No. 634 to H.R. 8800","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":105918,"prefix":null,"prefix_display":null,"first_name":"CHATRANE","nickname":null,"middle_name":null,"last_name":"BIRBAL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":39330,"prefix":"mr","prefix_display":"MR.","first_name":"TIMOTHY","nickname":null,"middle_name":"J","last_name":"BARTL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"4-16 Employer Groups Applaud House Funding Bill that Includes PBM Reform 4-20 support for the PBM Kickback Prohibition Act (H.R. 7895) 6-24 support for the Health Data Access, Transparency, and Affordability Act of 2026 (H.R. 9228)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":105918,"prefix":null,"prefix_display":null,"first_name":"CHATRANE","nickname":null,"middle_name":null,"last_name":"BIRBAL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":39330,"prefix":"mr","prefix_display":"MR.","first_name":"TIMOTHY","nickname":null,"middle_name":"J","last_name":"BARTL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/9cd1e3f3-c815-40c0-9fca-2828503fc9f1/","filing_uuid":"9cd1e3f3-c815-40c0-9fca-2828503fc9f1","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/9cd1e3f3-c815-40c0-9fca-2828503fc9f1/print/","filing_document_content_type":"text/html","income":null,"expenses":"584000.00","expenses_method":"C","expenses_method_display":"C","posted_by_name":"Jennifer Hatcher","dt_posted":"2026-07-20T15:06:34-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"251 18th Street S","registrant_address_2":"Suite 1200","registrant_different_address":false,"registrant_city":"Arlington","registrant_state":"VA","registrant_zip":"22202","registrant":{"id":15097,"url":"https://lda.gov/api/v1/registrants/15097/","house_registrant_id":30402,"name":"FOOD MARKETPLACE INC.","description":null,"address_1":"251 18th Street S","address_2":"Suite 1200","address_3":null,"address_4":null,"city":"Arlington","state":"VA","state_display":"Virginia","zip":"22202","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JENNIFER HATCHER","contact_telephone":"+1 202-220-0734","dt_updated":"2026-07-29T12:37:27.136166-04:00"},"client":{"id":120846,"url":"https://lda.gov/api/v1/clients/120846/","client_id":12,"name":"FOOD MARKETPLACE INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-10"},"lobbying_activities":[{"general_issue_code":"AGR","general_issue_code_display":"Agriculture","description":"Issues related to Farm Bill policies and programs Issues related to SNAP EBT transactions and modernization S. 835 - Reduce Food Loss and Waste Act of 2025 H.R. 4987 / S. 2541 - Food Date Labeling Act H.R. 5818 - Country of Origin Labeling Enforcement Act of 2025 H.R. 5954 - Beef Origin Labeling Accountability Act of 2025 S. 3065 - LABEL Act H.R. 7567 - Farm, Food, and National Security Act of 2026 S. 3949/H.R. 7658 - Enhanced Cybersecurity for SNAP Act H.R. 7469 - SNAP Online Access Act Agriculture Act of 2026 S. 4784 - National Defense Authorization Act for FY 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":28708,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"HATCHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":31224,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"HARIG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68741,"prefix":null,"prefix_display":null,"first_name":"PETER","nickname":null,"middle_name":null,"last_name":"MATZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":120268,"prefix":null,"prefix_display":null,"first_name":"CHRISTINE","nickname":null,"middle_name":null,"last_name":"POLLACK","suffix":null,"suffix_display":null},"covered_position":"Rep. E. Clay Shaw, Jr.","new":false},{"lobbyist":{"id":153643,"prefix":null,"prefix_display":null,"first_name":"ERIN","nickname":null,"middle_name":null,"last_name":"MCCARTHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":23,"name":"Agriculture, Dept of (USDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"Issues related to a national privacy standard, data privacy and security Issues related to retail crime, cargo theft, fraud and threats, food industry asset security S. 1404/H.R. 2853 - Combating Organized Retail Crime Act S. 836 - Children and Teens Online Privacy Protection Act H.R. 6291 - Children and Teens' Online Privacy Protection Act H.R. 6484 - Kids Online Safety Act H.R. 3149 - App Store Accountability Act H.R. 6333 - Parents Over Platforms Act H.R. 7757 - Kids Internet and Digital Safety (KIDS) Act H.R. 4966 / S. 3892 - Stop Price Gouging in Grocery Store Act of 2026 H.R. 8413 - SECURE Data Act H.R. 4737 - Apeel Reveal Act of 2025 H.R. 7502 - Recycled Materials Attribution Act H.R. 8895 - No Rigged Grocery Prices Act H.R. 9231 / S. 4724 - No Toxic Chemicals in Food Packaging Act of 2026 Issues related to consumer pricing and technology","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":28708,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"HATCHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":120268,"prefix":null,"prefix_display":null,"first_name":"CHRISTINE","nickname":null,"middle_name":null,"last_name":"POLLACK","suffix":null,"suffix_display":null},"covered_position":"Rep. E. Clay Shaw, Jr.","new":false},{"lobbyist":{"id":31224,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"HARIG","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"ENV","general_issue_code_display":"Environment/Superfund","description":"Congressional Review Act - EPA Management Rule - H.J.Res 38, S.J. Res. 14 H.J.Res.24 - Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Energy relating to \"Energy Conservation Program: Energy Conservation Standards for Walk-In Coolers and Walk-In Freezers\". H.J.Res.75 - Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Office of Energy Efficiency and Renewable Energy, Department of Energy relating to \"Energy Conservation Program: Energy Conservation Standards for Commercial Refrigerators, Freezers, and Refrigerator-Freezers\" S. 835 - Reduce Food Loss and Waste Act of 2025","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":28708,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"HATCHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":31224,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"HARIG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153643,"prefix":null,"prefix_display":null,"first_name":"ERIN","nickname":null,"middle_name":null,"last_name":"MCCARTHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":198,"name":"Natl Economic Council (NEC)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"FOO","general_issue_code_display":"Food Industry (safety, labeling, etc.)","description":"Issues relating to federal food safety policies and regulations: FDAs food traceability rule and the Food Safety Modernization Act (FSMA) Issues related to SNAP waivers restricting food purchases Issues relating to the operation of federal feeding programs, e.g., SNAP, WIC, and the Summer EBT program Issues related to food prices, food industry supply chain Uniformity of food ingredient labeling, disclosure and GRAS reform Issues relating to Farm Bill nutrition policies and programs Issues relating to SNAP EBT transactions and modernization SNAP error rate H.R. 4158 - Ensuring Fee-Free Benefit Transactions Act H.R. 4692 - MAMDANI Act S. 3934/H.R. 6199 - Medical Nutrition Therapy Act S.272 - Protect Infant Formula from Contamination Act H.R. 7567 - Farm, Food, and National Security Act of 2026 H.R. 7469 - SNAP Online Access Act Agriculture Act of 2026 H.R. 7867 - Infant Formula Safety Modernization Act of 2026 H.R. 8430 - Federal and State Food Safety Information Sharing Act of 2026","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":28708,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"HATCHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68741,"prefix":null,"prefix_display":null,"first_name":"PETER","nickname":null,"middle_name":null,"last_name":"MATZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":31224,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"HARIG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":120268,"prefix":null,"prefix_display":null,"first_name":"CHRISTINE","nickname":null,"middle_name":null,"last_name":"POLLACK","suffix":null,"suffix_display":null},"covered_position":"Rep. E. Clay Shaw, Jr.","new":false},{"lobbyist":{"id":153643,"prefix":null,"prefix_display":null,"first_name":"ERIN","nickname":null,"middle_name":null,"last_name":"MCCARTHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":23,"name":"Agriculture, Dept of (USDA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"LBR","general_issue_code_display":"Labor Issues/Antitrust/Workplace","description":"Issues related to food industry workforce, workforce shortage, immigration, work permits, apprenticeships, WIOA reauthorization Issues related to wage and hour policies, OSHA policies, NLRB policies Richard L. Trumka Protecting the Right to Organize (PRO Act), H.R. 20/S. 852 H.R. 1319 - Modern Worker Empowerment Act H.R. 4366 - Save Local Businesses Act H.R. 4896/S. 2613 - Warehouse Worker Protection Act H.R. 4393 - Dignity Act H.R. 5494 - Essential Workers for Economic Advancement Act H.R. 5408/S. 844 - Faster Labor Contracts Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":28708,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"HATCHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":120268,"prefix":null,"prefix_display":null,"first_name":"CHRISTINE","nickname":null,"middle_name":null,"last_name":"POLLACK","suffix":null,"suffix_display":null},"covered_position":"Rep. E. Clay Shaw, Jr.","new":false},{"lobbyist":{"id":31224,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"HARIG","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"MON","general_issue_code_display":"Minting/Money/Gold Standard","description":"Issues related to retail payments market, swipe fee reform Regulation II - debit routing and debit regulated rate S. 1582 - GENIUS Act Issues related to penny/coin circulation H.R. 3074/S. 1525 - Common Cents Act Issues related to Dodd Frank section 1033/open banking Issues related to stablecoins/cryptocurrency S. 3623/H.R. 7035 - Credit Card Competition Act Digital Commodity Intermediaries Act S. 3849/H.R. 7484 - Community Bank Relief Act Issues related to financial data privacy, Gramm-Leach-Bliley Act H.R. 8398 - GUARD Financial Data Act Issues related to national bank and credit union non-interest charges and fees","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":28708,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"HATCHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":120268,"prefix":null,"prefix_display":null,"first_name":"CHRISTINE","nickname":null,"middle_name":null,"last_name":"POLLACK","suffix":null,"suffix_display":null},"covered_position":"Rep. E. Clay Shaw, Jr.","new":false}],"government_entities":[{"id":62,"name":"Federal Reserve System"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":90,"name":"Small Business Administration (SBA)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Proposals addressing pharmacy benefit manager (PBM) practices, including those focused on PBM/pharmacy contracts, pharmacy reimbursement, direct and indirect remuneration (DIR), and transparency Issues relating to pharmacy reimbursement, scope of practice, access to pharmacist-provided care Patients Before Middlemen Act (S. 882) Protecting Pharmacies in Medicaid Act (S. 927) Main Street Pharmacy Access Act (H.R. 3164/S. 2426) PBM Reform Act (H.R. 4317) S.3345 - PBM Price Transparency and Accountability Act H.R.6703 - Lower Health Care Premiums for All Americans Act H.R. 7148 - Consolidated Appropriations Act, 2026 Administration prescription drug pricing platform (Trump Rx)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":28708,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"HATCHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68741,"prefix":null,"prefix_display":null,"first_name":"PETER","nickname":null,"middle_name":null,"last_name":"MATZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":120268,"prefix":null,"prefix_display":null,"first_name":"CHRISTINE","nickname":null,"middle_name":null,"last_name":"POLLACK","suffix":null,"suffix_display":null},"covered_position":"Rep. E. Clay Shaw, Jr.","new":false},{"lobbyist":{"id":31224,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"HARIG","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"S. 587 / H.R. 1301 - Death Tax Repeal Act of 2025 H.R. 1705 - Supporting Innovation in Agriculture Act of 2025 H.R. 1707 - Grown in America Act of 2025 Issues related to WOTC Improve and Enhance the Work Opportunity Tax Credit, H.R. 1177/S. 492/H.R. 6231/S. 3265 Helping to Encourage Real Opportunity (HERO) for Youth Act, S. 1211 H.R. 1 - One Big Beautiful Bill Act, Title VII, Subtitle A - Tax & Related Regulatory Issues Issues related to potential tax extenders package Issues related to reconciliation tax package","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":28708,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"HATCHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":31224,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"HARIG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":120268,"prefix":null,"prefix_display":null,"first_name":"CHRISTINE","nickname":null,"middle_name":null,"last_name":"POLLACK","suffix":null,"suffix_display":null},"covered_position":"Rep. E. Clay Shaw, Jr.","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TRA","general_issue_code_display":"Transportation","description":"Issues related to food industry supply chain, trucking workforce, truck parking, cargo theft Issues related to gross vehicle weights Issues related to surface transportation reauthorization H.R. 8870 - BUILD America 250 Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":28708,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"HATCHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":120268,"prefix":null,"prefix_display":null,"first_name":"CHRISTINE","nickname":null,"middle_name":null,"last_name":"POLLACK","suffix":null,"suffix_display":null},"covered_position":"Rep. E. Clay Shaw, Jr.","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Issues related to U.S. trade and tariff policy H.R. 5446 - No Tariffs on Groceries Act S. 2868 - India Shrimp Tariff Act Issues Related to Renewal of the USMCA Issues related to Section 301 Investigations Issues Related to IEEPA Tariff Refunds","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":28708,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"HATCHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":31224,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"HARIG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":120268,"prefix":null,"prefix_display":null,"first_name":"CHRISTINE","nickname":null,"middle_name":null,"last_name":"POLLACK","suffix":null,"suffix_display":null},"covered_position":"Rep. E. Clay Shaw, Jr.","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues relating to the impact of pharmacy benefit manager (PBM) practices on employer-sponsored health care/ERISA, Medicare, Medicaid, and Tricare PBM Kickback Prohibition Act (H.R. 7895)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":28708,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"HATCHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68741,"prefix":null,"prefix_display":null,"first_name":"PETER","nickname":null,"middle_name":null,"last_name":"MATZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TEC","general_issue_code_display":"Telecommunications","description":"Issues related to lower 900MHz band","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":120268,"prefix":null,"prefix_display":null,"first_name":"CHRISTINE","nickname":null,"middle_name":null,"last_name":"POLLACK","suffix":null,"suffix_display":null},"covered_position":"Rep. E. Clay Shaw, Jr.","new":false}],"government_entities":[{"id":53,"name":"Federal Communications Commission (FCC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"FIN","general_issue_code_display":"Financial Institutions/Investments/Securities","description":"Issues related to the launch of Trump Accounts","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":31224,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"HARIG","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/b6ff2b38-c35d-44b1-ab07-83a8b3bc4a30/","filing_uuid":"b6ff2b38-c35d-44b1-ab07-83a8b3bc4a30","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/b6ff2b38-c35d-44b1-ab07-83a8b3bc4a30/print/","filing_document_content_type":"text/html","income":null,"expenses":"3282990.00","expenses_method":"C","expenses_method_display":"C","posted_by_name":"Jonathan Heafitz","dt_posted":"2026-07-20T17:50:51-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"325 7th Street NW, 9th Floor","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":31348,"url":"https://lda.gov/api/v1/registrants/31348/","house_registrant_id":34004,"name":"PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION","description":"Issues relating to prescription drug benefits","address_1":"325 7th Street NW, 9th Floor","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JONATHAN HEAFITZ","contact_telephone":"+1 202-756-5735","dt_updated":"2026-07-22T16:58:34.643878-04:00"},"client":{"id":138221,"url":"https://lda.gov/api/v1/clients/138221/","client_id":12,"name":"PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION","general_description":"no change","client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-07-01"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S.4509/ H.R. 8779; Patients Before Monopolies Act S. 526; Pharmacy Benefit Manager Transparency Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3822; Break Up Big Medicine Act S. 4189; INSLUN Act of 2026 H.R. 1244; Reducing Drug Prices for Seniors Act H.R. 4317; PBM Reform Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":44250,"prefix":"mr","prefix_display":"MR.","first_name":"JONATHAN","nickname":null,"middle_name":"M","last_name":"HEAFITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143598,"prefix":null,"prefix_display":null,"first_name":"LUCIA","nickname":null,"middle_name":null,"last_name":"LEBENS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147046,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"THREADGILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149676,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"BUSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153596,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MARIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"S.1637/H.R 7871; Medicaid VBPs for Patients Act S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S. 2617/H.R. 1244; Reducing Drug Prices for Seniors Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 1041; Affordable Prescriptions for Patients Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3345; PBM Price Transparency and Accountability Act H.R. 4317; PBM Reform Act H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services S.4323/ H.R. 8143; Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":44250,"prefix":"mr","prefix_display":"MR.","first_name":"JONATHAN","nickname":null,"middle_name":"M","last_name":"HEAFITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143598,"prefix":null,"prefix_display":null,"first_name":"LUCIA","nickname":null,"middle_name":null,"last_name":"LEBENS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147046,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"THREADGILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149676,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"BUSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153596,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MARIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S.1637/H.R 7871; Medicaid VBPs for Patients Act S. 4323/ H.R. 8143; Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026 S. 2355/H.R. 5582; Patients Deserve Price Tags Act S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S.4509/ H.R. 8779; Patients Before Monopolies Act S. 526; Pharmacy Benefit Manager Transparency Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 1041; Affordable Prescriptions for Patients Act S. 1095; Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act S. 1096; Preserve Access to Affordable Generics and Biosimilars Act S. 1097; Interagency Patent Coordination and Improvements Act of 2025 S. 1414; Expedited Access to Biosimilars Act S. 2617; Reducing Drug Prices for Seniors Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3345; PBM Price Transparency and Accountability Act S. 3349; PBM Disclosure Act S. 3549; PBM Fiduciary, Accountability, Integrity, and Reform Act S. 3822; Break Up Big Medicine Act S. 4189; INSLUN Act of 2026 H.R. 1244; Reducing Drug Prices for Seniors Act H.R. 2214; Delinking Revenue from Unfair Gouging Act H.R. 4317; PBM Reform Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 4570; Interagency Patent Coordination and Improvements Act of 2025 H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program H.R. 6837; To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services oSec. 6702- Full Rebate Pass Through to Plans H.R. 7895; PBM Kickback Prohibition Act H.R. 8324; Great American Healthcare Plan H.R. 9228; Health Data Access, Transparency, and Affordability Act of 2026 H.R. 9486; Health Data Access, Transparency and Affordability Act H.R. 9117; Clear Healthcare Expense Cost Knowledge Act H.R. 9393; Lower Cost, More Transparency Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":44250,"prefix":"mr","prefix_display":"MR.","first_name":"JONATHAN","nickname":null,"middle_name":"M","last_name":"HEAFITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143598,"prefix":null,"prefix_display":null,"first_name":"LUCIA","nickname":null,"middle_name":null,"last_name":"LEBENS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147046,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"THREADGILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149676,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"BUSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153596,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MARIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"},{"id":90,"name":"Small Business Administration (SBA)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/b15d1edf-c45b-4810-a85b-9abb43114948/","filing_uuid":"b15d1edf-c45b-4810-a85b-9abb43114948","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/b15d1edf-c45b-4810-a85b-9abb43114948/print/","filing_document_content_type":"text/html","income":null,"expenses":"270000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Joel Aurora, Attorney & Agent","dt_posted":"2026-07-20T17:55:30-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"4550 Montgomery Avenue","registrant_address_2":"Suite 1100N","registrant_different_address":false,"registrant_city":"Bethesda","registrant_state":"MD","registrant_zip":"20814","registrant":{"id":60195,"url":"https://lda.gov/api/v1/registrants/60195/","house_registrant_id":35346,"name":"CYSTIC FIBROSIS FOUNDATION","description":"Foundation working to find a cure for cystic fibrosis.","address_1":"4550 Montgomery Avenue","address_2":"Suite 1100N","address_3":null,"address_4":null,"city":"Bethesda","state":"MD","state_display":"Maryland","zip":"20814","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MARY DWIGHT","contact_telephone":"+1 301-841-2639","dt_updated":"2026-07-30T15:20:39.075688-04:00"},"client":{"id":160886,"url":"https://lda.gov/api/v1/clients/160886/","client_id":12,"name":"CYSTIC FIBROSIS FOUNDATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MD","state_display":"Maryland","country":"US","country_display":"United States of America","ppb_state":"MD","ppb_state_display":"Maryland","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2014-01-17"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 6837: TO AMEND THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974 TO ENSURE THAT PHARMACY BENEFIT MANAGERS ARE CONSIDERED FIDUCIARIES, AND FOR OTHER PURPOSES; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS H.R. 7879: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2026; ALL PROVISIONS H.R. 7895: PBM KICKBACK PROHIBITION ACT; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 3549: PBM FIDUCIARY ACCOUNTABILITY, INTEGRITY, AND REFORM (FAIR) ACT S. 4875: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS ON NEW MEDICAID WORK REPORTING REQUIREMENTS AND DEFINITION OF MEDICAL FRAILTY DESCRIBED IN CMS IFR ON 6/1 GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HDHPS PAIRED WITH HSAS GENERAL DISCUSSION ON ALTERNATIVE FUNDING PROGRAMS (AFPS) GENERAL DISCUSSION ON DRUG PRICING REFORM GENERAL DISCUSSION ON HEALTH COVERAGE REFORM GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; ISSUES RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL BUDGET RECONCILIATION LEGISLATION CFF COMMENTS ON PRIOR AUTHORIZATION PROPOSED RULE; CFF SUBMITS COMMENTS FOR A PROPOSED RULE ON INTEROPERABILITY AND PRIOR AUTHORIZATION FOR DRUGS AND RELATED RFIS PPC STATEMENT IN RESPONSE TO CMS WORK REPORTING RULE; CFF JOINS PATIENT AND HEALTH GROUPS IN STATEMENT EXPRESSING CONCERN ABOUT THE CMS INTERIM FINAL RULE ON THE MEDICAID WORK CFF SENDS COMMENTS TO DOL ON PBM RULE; CFF SUBMITS COMMENTS TO DOL ON THEIR PROPOSED RULE TO IMPROVE TRANSPARENCY OF PHARMACY BENEFIT MANAGERS","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":46372,"prefix":"mr","prefix_display":"MR.","first_name":"MARY","nickname":null,"middle_name":"B","last_name":"DWIGHT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66434,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"ELIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152717,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"SHERWOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 6837: TO AMEND THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974 TO ENSURE THAT PHARMACY BENEFIT MANAGERS ARE CONSIDERED FIDUCIARIES, AND FOR OTHER PURPOSES; ALL PROVISIONS H.R. 7895: PBM KICKBACK PROHIBITION ACT; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 3549: PBM FIDUCIARY ACCOUNTABILITY, INTEGRITY, AND REFORM (FAIR) ACT GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS ON NEW MEDICAID WORK REPORTING REQUIREMENTS AND DEFINITION OF MEDICAL FRAILTY DESCRIBED IN CMS IFR ON 6/1 GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HDHPS PAIRED WITH HSAS GENERAL DISCUSSION ON ALTERNATIVE FUNDING PROGRAMS (AFPS) GENERAL DISCUSSION ON DRUG PRICING REFORM GENERAL DISCUSSION ON HEALTH COVERAGE REFORM GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; ISSUES RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL BUDGET RECONCILIATION LEGISLATION CFF COMMENTS ON PRIOR AUTHORIZATION PROPOSED RULE; CFF SUBMITS COMMENTS FOR A PROPOSED RULE ON INTEROPERABILITY AND PRIOR AUTHORIZATION FOR DRUGS AND RELATED RFIS CFF SENDS COMMENTS TO DOL ON PBM RULE; CFF SUBMITS COMMENTS TO DOL ON THEIR PROPOSED RULE TO IMPROVE TRANSPARENCY OF PHARMACY BENEFIT MANAGERS","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":46372,"prefix":"mr","prefix_display":"MR.","first_name":"MARY","nickname":null,"middle_name":"B","last_name":"DWIGHT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152717,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"SHERWOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66434,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"ELIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; ISSUES RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSION ON FY2027 APPROPRIATIONS; ISSUES RELATED TO HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, OBLIGATE STABLE PACE OF SPENDING FY26 FUNDS GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL BUDGET RECONCILIATION LEGISLATION GENERAL DISCUSSION OPPOSING OMBS PROPOSED RULE, REGULATION FOR FEDERAL FINANCIAL ASSISTANCE, RELEASED 5/29","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66434,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"ELIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":46372,"prefix":"mr","prefix_display":"MR.","first_name":"MARY","nickname":null,"middle_name":"B","last_name":"DWIGHT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152717,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"SHERWOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS H.R. 7879: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2026; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 4875: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; ISSUES RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSION ON FY2027 APPROPRIATIONS; ISSUES RELATED TO HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, OBLIGATE STABLE PACE OF SPENDING FY26 FUNDS GENERAL DISCUSSION OPPOSING OMBS PROPOSED RULE, REGULATION FOR FEDERAL FINANCIAL ASSISTANCE, RELEASED 5/29 FOLLOW UP ON ALTERNATIVE FUNDING PROGRAMS AND IMPORTATION OF DRUGS; CFF SENDS LETTER TO FDA AND CDER REGARDING A CITIZEN PETITION CONCERNING ALTERNATIVE FUNDING PROGRAMS (AFPS) COMMENTS ON DRAFT GUIDANCE FOR THE PLAUSIBLE MECHANISM FRAMEWORK; CFF SUBMITS COMMENTS TO THE FDA ON DRAFT GUIDANCE FOR THE PLAUSIBLE MECHANISM FRAMEWORK, URGING A FLEXIBLE APPROACH TO SUPPORT THE DEVELOPMENT OF GENE EDITING AND OTHER THERAPIES FOR PEOPLE WITH ULTRA-RARE MUTATIONS","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":46372,"prefix":"mr","prefix_display":"MR.","first_name":"MARY","nickname":null,"middle_name":"B","last_name":"DWIGHT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66434,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"ELIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152717,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"SHERWOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS ON NEW MEDICAID WORK REPORTING REQUIREMENTS AND DEFINITION OF MEDICAL FRAILTY DESCRIBED IN CMS IFR ON 6/1 GENERAL DISCUSSION ON HEALTH COVERAGE REFORM GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL BUDGET RECONCILIATION LEGISLATION CFF COMMENTS ON PRIOR AUTHORIZATION PROPOSED RULE; CFF SUBMITS COMMENTS FOR A PROPOSED RULE ON INTEROPERABILITY AND PRIOR AUTHORIZATION FOR DRUGS AND RELATED RFIS PPC STATEMENT IN RESPONSE TO CMS WORK REPORTING RULE; CFF JOINS PATIENT AND HEALTH GROUPS IN STATEMENT EXPRESSING CONCERN ABOUT THE CMS INTERIM FINAL RULE ON THE MEDICAID WORK","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152717,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"SHERWOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66434,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"ELIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":46372,"prefix":"mr","prefix_display":"MR.","first_name":"MARY","nickname":null,"middle_name":"B","last_name":"DWIGHT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"GENERAL DISCUSSION ON DRUG PRICING REFORM","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66434,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"ELIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152717,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"SHERWOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/b15d1edf-c45b-4810-a85b-9abb43114948/","filing_uuid":"b15d1edf-c45b-4810-a85b-9abb43114948","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/b15d1edf-c45b-4810-a85b-9abb43114948/print/","filing_document_content_type":"text/html","income":null,"expenses":"270000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Joel Aurora, Attorney & Agent","dt_posted":"2026-07-20T17:55:30-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"4550 Montgomery Avenue","registrant_address_2":"Suite 1100N","registrant_different_address":false,"registrant_city":"Bethesda","registrant_state":"MD","registrant_zip":"20814","registrant":{"id":60195,"url":"https://lda.gov/api/v1/registrants/60195/","house_registrant_id":35346,"name":"CYSTIC FIBROSIS FOUNDATION","description":"Foundation working to find a cure for cystic fibrosis.","address_1":"4550 Montgomery Avenue","address_2":"Suite 1100N","address_3":null,"address_4":null,"city":"Bethesda","state":"MD","state_display":"Maryland","zip":"20814","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MARY DWIGHT","contact_telephone":"+1 301-841-2639","dt_updated":"2026-07-30T15:20:39.075688-04:00"},"client":{"id":160886,"url":"https://lda.gov/api/v1/clients/160886/","client_id":12,"name":"CYSTIC FIBROSIS FOUNDATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MD","state_display":"Maryland","country":"US","country_display":"United States of America","ppb_state":"MD","ppb_state_display":"Maryland","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2014-01-17"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 6837: TO AMEND THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974 TO ENSURE THAT PHARMACY BENEFIT MANAGERS ARE CONSIDERED FIDUCIARIES, AND FOR OTHER PURPOSES; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS H.R. 7879: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2026; ALL PROVISIONS H.R. 7895: PBM KICKBACK PROHIBITION ACT; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 3549: PBM FIDUCIARY ACCOUNTABILITY, INTEGRITY, AND REFORM (FAIR) ACT S. 4875: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS ON NEW MEDICAID WORK REPORTING REQUIREMENTS AND DEFINITION OF MEDICAL FRAILTY DESCRIBED IN CMS IFR ON 6/1 GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HDHPS PAIRED WITH HSAS GENERAL DISCUSSION ON ALTERNATIVE FUNDING PROGRAMS (AFPS) GENERAL DISCUSSION ON DRUG PRICING REFORM GENERAL DISCUSSION ON HEALTH COVERAGE REFORM GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; ISSUES RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL BUDGET RECONCILIATION LEGISLATION CFF COMMENTS ON PRIOR AUTHORIZATION PROPOSED RULE; CFF SUBMITS COMMENTS FOR A PROPOSED RULE ON INTEROPERABILITY AND PRIOR AUTHORIZATION FOR DRUGS AND RELATED RFIS PPC STATEMENT IN RESPONSE TO CMS WORK REPORTING RULE; CFF JOINS PATIENT AND HEALTH GROUPS IN STATEMENT EXPRESSING CONCERN ABOUT THE CMS INTERIM FINAL RULE ON THE MEDICAID WORK CFF SENDS COMMENTS TO DOL ON PBM RULE; CFF SUBMITS COMMENTS TO DOL ON THEIR PROPOSED RULE TO IMPROVE TRANSPARENCY OF PHARMACY BENEFIT MANAGERS","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":46372,"prefix":"mr","prefix_display":"MR.","first_name":"MARY","nickname":null,"middle_name":"B","last_name":"DWIGHT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66434,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"ELIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152717,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"SHERWOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 6837: TO AMEND THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974 TO ENSURE THAT PHARMACY BENEFIT MANAGERS ARE CONSIDERED FIDUCIARIES, AND FOR OTHER PURPOSES; ALL PROVISIONS H.R. 7895: PBM KICKBACK PROHIBITION ACT; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 3549: PBM FIDUCIARY ACCOUNTABILITY, INTEGRITY, AND REFORM (FAIR) ACT GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS ON NEW MEDICAID WORK REPORTING REQUIREMENTS AND DEFINITION OF MEDICAL FRAILTY DESCRIBED IN CMS IFR ON 6/1 GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HDHPS PAIRED WITH HSAS GENERAL DISCUSSION ON ALTERNATIVE FUNDING PROGRAMS (AFPS) GENERAL DISCUSSION ON DRUG PRICING REFORM GENERAL DISCUSSION ON HEALTH COVERAGE REFORM GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; ISSUES RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL BUDGET RECONCILIATION LEGISLATION CFF COMMENTS ON PRIOR AUTHORIZATION PROPOSED RULE; CFF SUBMITS COMMENTS FOR A PROPOSED RULE ON INTEROPERABILITY AND PRIOR AUTHORIZATION FOR DRUGS AND RELATED RFIS CFF SENDS COMMENTS TO DOL ON PBM RULE; CFF SUBMITS COMMENTS TO DOL ON THEIR PROPOSED RULE TO IMPROVE TRANSPARENCY OF PHARMACY BENEFIT MANAGERS","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":46372,"prefix":"mr","prefix_display":"MR.","first_name":"MARY","nickname":null,"middle_name":"B","last_name":"DWIGHT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152717,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"SHERWOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66434,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"ELIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; ISSUES RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSION ON FY2027 APPROPRIATIONS; ISSUES RELATED TO HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, OBLIGATE STABLE PACE OF SPENDING FY26 FUNDS GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL BUDGET RECONCILIATION LEGISLATION GENERAL DISCUSSION OPPOSING OMBS PROPOSED RULE, REGULATION FOR FEDERAL FINANCIAL ASSISTANCE, RELEASED 5/29","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66434,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"ELIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":46372,"prefix":"mr","prefix_display":"MR.","first_name":"MARY","nickname":null,"middle_name":"B","last_name":"DWIGHT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152717,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"SHERWOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS H.R. 7879: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2026; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 4875: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; ISSUES RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSION ON FY2027 APPROPRIATIONS; ISSUES RELATED TO HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, OBLIGATE STABLE PACE OF SPENDING FY26 FUNDS GENERAL DISCUSSION OPPOSING OMBS PROPOSED RULE, REGULATION FOR FEDERAL FINANCIAL ASSISTANCE, RELEASED 5/29 FOLLOW UP ON ALTERNATIVE FUNDING PROGRAMS AND IMPORTATION OF DRUGS; CFF SENDS LETTER TO FDA AND CDER REGARDING A CITIZEN PETITION CONCERNING ALTERNATIVE FUNDING PROGRAMS (AFPS) COMMENTS ON DRAFT GUIDANCE FOR THE PLAUSIBLE MECHANISM FRAMEWORK; CFF SUBMITS COMMENTS TO THE FDA ON DRAFT GUIDANCE FOR THE PLAUSIBLE MECHANISM FRAMEWORK, URGING A FLEXIBLE APPROACH TO SUPPORT THE DEVELOPMENT OF GENE EDITING AND OTHER THERAPIES FOR PEOPLE WITH ULTRA-RARE MUTATIONS","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":46372,"prefix":"mr","prefix_display":"MR.","first_name":"MARY","nickname":null,"middle_name":"B","last_name":"DWIGHT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66434,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"ELIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152717,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"SHERWOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS ON NEW MEDICAID WORK REPORTING REQUIREMENTS AND DEFINITION OF MEDICAL FRAILTY DESCRIBED IN CMS IFR ON 6/1 GENERAL DISCUSSION ON HEALTH COVERAGE REFORM GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL BUDGET RECONCILIATION LEGISLATION CFF COMMENTS ON PRIOR AUTHORIZATION PROPOSED RULE; CFF SUBMITS COMMENTS FOR A PROPOSED RULE ON INTEROPERABILITY AND PRIOR AUTHORIZATION FOR DRUGS AND RELATED RFIS PPC STATEMENT IN RESPONSE TO CMS WORK REPORTING RULE; CFF JOINS PATIENT AND HEALTH GROUPS IN STATEMENT EXPRESSING CONCERN ABOUT THE CMS INTERIM FINAL RULE ON THE MEDICAID WORK","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152717,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"SHERWOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66434,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"ELIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":46372,"prefix":"mr","prefix_display":"MR.","first_name":"MARY","nickname":null,"middle_name":"B","last_name":"DWIGHT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"GENERAL DISCUSSION ON DRUG PRICING REFORM","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66434,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"ELIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152717,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"SHERWOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/c7058672-76ad-4fa4-93ab-0817215e9323/","filing_uuid":"c7058672-76ad-4fa4-93ab-0817215e9323","filing_type":"2A","filing_type_display":"2nd Quarter - Amendment","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/c7058672-76ad-4fa4-93ab-0817215e9323/print/","filing_document_content_type":"text/html","income":null,"expenses":"70000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Scott Frey","dt_posted":"2026-09-24T12:31:17-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2033 K Street NW","registrant_address_2":"Suite 450","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":401010854,"url":"https://lda.gov/api/v1/registrants/401010854/","house_registrant_id":42171,"name":"ALLIANCE FOR AGING RESEARCH","description":"Non-profit healthcare advocacy organization","address_1":"2033 K Street NW","address_2":"Suite 450","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"SCOTT FREY","contact_telephone":"+1 571-289-1385","dt_updated":"2026-09-24T12:38:43.419803-04:00"},"client":{"id":196811,"url":"https://lda.gov/api/v1/clients/196811/","client_id":12,"name":"ALLIANCE FOR AGING RESEARCH","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2015-05-04"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"-Alzheimer's Screening & Prevention Act (ASAP) H.R. 6130/ S. 3267 -Lowering Costs for Caregivers Act (S. 1565/H.R. 138) -Federal vaccine messaging -Impacts of IRA on Older Americans -National Institutes of Health advance funding of multi-year research grants -Clinical Trials Modernization Act H.R.7905 -Patient Access to Cancer and Complex Therapies Act H.R. 4299 -Diabetes Foot Health and Modernization Access Act H.R. 7905 -Oppose PBM Kickbacks H.R. 7895 -Oppose Codification of MFN Drug Pricing Proposals (no bill) -End Coverage with Evidence Development for Alzheimer's medications and Trans Catheter Aortic Valve Replacement","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138576,"prefix":"ms","prefix_display":"MS.","first_name":"ADINA","nickname":null,"middle_name":"ROSE","last_name":"LASSER","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":149533,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"FREY","suffix":null,"suffix_display":null},"covered_position":"Deputy Commissioner for Legislation and Congressional Affairs -- SSA, Chief of Staff -- SSA, Senior Strategic Advisor -- Office of National Drug Control Policy","new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"-Implementation of Medicare Part D beneficiary affordability provisions -Nursing home quality measures -Implementation of the Medicare Direct Negotiation Program and its impact on older adults -Utilization management reform in Medicare -Increasing Medication Access for Seniors Act (H.R.6401) -End Coverage with Evidence Development for Alzheimer's Medications and TAVR","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138576,"prefix":"ms","prefix_display":"MS.","first_name":"ADINA","nickname":null,"middle_name":"ROSE","last_name":"LASSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149533,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"FREY","suffix":null,"suffix_display":null},"covered_position":"Deputy Commissioner for Legislation and Congressional Affairs -- SSA, Chief of Staff -- SSA, Senior Strategic Advisor -- Office of National Drug Control Policy","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"-FY27 report language for the Food and Drug Administration on antipsychotics black box warning -FY27 report language for the Medicare Program antipsychotics measure -FY27 report language for the Medicare Prescription Payment Plan -FY27 report language for utilization management reform in the Medicare program -FY27 medical research funding -FY27 funding for FDA's Neurology Drug Program -FY 27 Appropriations H.R. 9260 and pending Senate bill, Increase Funding for Programs benefitting older adults at HHS, including ASPE, NIH, CDC HRSA, ARHQ, FDA, CMS, ACL","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138576,"prefix":"ms","prefix_display":"MS.","first_name":"ADINA","nickname":null,"middle_name":"ROSE","last_name":"LASSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149533,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"FREY","suffix":null,"suffix_display":null},"covered_position":"Deputy Commissioner for Legislation and Congressional Affairs -- SSA, Chief of Staff -- SSA, Senior Strategic Advisor -- Office of National Drug Control Policy","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/492d17a3-9a97-4205-a305-bca77bafc360/","filing_uuid":"492d17a3-9a97-4205-a305-bca77bafc360","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/492d17a3-9a97-4205-a305-bca77bafc360/print/","filing_document_content_type":"text/html","income":null,"expenses":"670000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Alison Esquea","dt_posted":"2026-10-15T14:16:37-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"700 12th St NW","registrant_address_2":"Ste. 700","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":401105208,"url":"https://lda.gov/api/v1/registrants/401105208/","house_registrant_id":null,"name":"CAMBIA HEALTH SOLUTIONS","description":"Innovative health care solutions","address_1":"601 13th St. NW, Ste. 900 South","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ALISON ESQUEA","contact_telephone":"+1 202-253-5455","dt_updated":"2026-07-27T16:33:38.902734-04:00"},"client":{"id":203401,"url":"https://lda.gov/api/v1/clients/203401/","client_id":12,"name":"CAMBIA HEALTH SOLUTIONS","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-02-19"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Affordable Care Act and Extending Enhanced APTCs (H.R. 247; S. 46), Individual Market/ACA exchanges; Fraudulent Enrollments in Qualified Health Plans (S. 976, HR 2079), Behavioral Health, Employer-Provided Health Coverage; Surprise Billing (S. 2420, H.R. 4710); Cybersecurity; Health IT, Health Care Innovation, Transparency & PBMs (S. 891, H.R. 6703), PBM Compensation (H.R. 7895), Prescription Drugs (S. 1954, S. 1096, S.1040), Price Transparency (S. 2355, H.R. 9393, H.R. 9397, H.R. 9645, H.R. 9390), Prior Authorization (H.R. 9396), 340B, Insulin (S. 4189), Corporate Practice of Medicine, Anticompetitive Contracting (H.R. 6248, S. 4027).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70189,"prefix":null,"prefix_display":null,"first_name":"ALISON","nickname":null,"middle_name":null,"last_name":"ESQUEA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145155,"prefix":null,"prefix_display":null,"first_name":"RYNE","nickname":null,"middle_name":null,"last_name":"CARNEY","suffix":null,"suffix_display":null},"covered_position":"Intern - Rep. Ed Perlmutter","new":false},{"lobbyist":{"id":153403,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"HRUBY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Medicare Advantage: Star Ratings, Risk Adjustment, Supplemental Benefits (H.R. 5746, H.R. 5243), No UPCODE Act (S. 1105), Medicare Prior Authorization and Electronic Prior Authorization (H.R. 3514, H.R. 8375), Provider Directories (S. 891), Telehealth Extending Flexibilities (H.R. 4206, S. 1261), Transparency & PBMs (S. 882; S. 891, S. 3345, H.R. 9392), Physician Fee Schedule, Site Neutrality (H.R. 7149), Broker/Agents (H.R. 9395), MLR (H.R. 9644).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70189,"prefix":null,"prefix_display":null,"first_name":"ALISON","nickname":null,"middle_name":null,"last_name":"ESQUEA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145155,"prefix":null,"prefix_display":null,"first_name":"RYNE","nickname":null,"middle_name":null,"last_name":"CARNEY","suffix":null,"suffix_display":null},"covered_position":"Intern - Rep. Ed Perlmutter","new":false},{"lobbyist":{"id":153403,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"HRUBY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/eb504afd-06cd-4cdf-842c-5940a229d8d4/","filing_uuid":"eb504afd-06cd-4cdf-842c-5940a229d8d4","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/eb504afd-06cd-4cdf-842c-5940a229d8d4/print/","filing_document_content_type":"text/html","income":null,"expenses":"65000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Scott Frey","dt_posted":"2026-10-19T14:20:28-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2033 K Street NW","registrant_address_2":"Suite 450","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":401010854,"url":"https://lda.gov/api/v1/registrants/401010854/","house_registrant_id":42171,"name":"ALLIANCE FOR AGING RESEARCH","description":"Non-profit healthcare advocacy organization","address_1":"2033 K Street NW","address_2":"Suite 450","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"SCOTT FREY","contact_telephone":"+1 571-289-1385","dt_updated":"2026-09-24T12:38:43.419803-04:00"},"client":{"id":196811,"url":"https://lda.gov/api/v1/clients/196811/","client_id":12,"name":"ALLIANCE FOR AGING RESEARCH","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2015-05-04"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"-Alzheimer's Screening & Prevention Act (ASAP) H.R. 6130/ S. 3267 -Lowering Costs for Caregivers Act (S. 1565/H.R. 138) -Federal vaccine messaging -Impacts of IRA on Older Americans -National Institutes of Health advance funding of multi-year research grants -Clinical Trials Modernization Act H.R.3251/S 4440 -Patient Access to Cancer and Complex Therapies Act H.R. 4299 -Diabetes Foot Health and Modernization Access Act H.R. 7905 -Oppose PBM Kickbacks H.R. 7895 -Oppose Codification of MFN Drug Pricing Proposals (no bill) -End Coverage with Evidence Development for Alzheimer's medications and Trans Catheter Aortic Valve Replacement -Update CMS Long stay antipsychotic Quality measure -Update FDA Antipsychotic black box warning -Funding for NIH (HR 9260) -PASTEUR Act (HR 7352/S 4975) -Biosimilar Access and Affordability Act (HR10628/S5571) -CMS Fixed Dose Combination Therapies proposed policy -OMB Proposed Uniform Guidance on Federal Grantmaking (HR 6500) -Alzheimer's Early Detection Act (HR 9823) -CMS reporting requirements for Medicare Prescription Payment Program (HR 9260) -CMS Trans Catheter Aortic Valve Replacement NCD proposal","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":149533,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"FREY","suffix":null,"suffix_display":null},"covered_position":"Deputy Commissioner for Legislation and Congressional Affairs -- SSA, Chief of Staff -- SSA, Senior Strategic Advisor -- Office of National Drug Control Policy","new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"-Implementation of Medicare Part D beneficiary affordability provisions -Nursing home quality measures -Implementation of the Medicare Direct Negotiation Program and its impact on older adults -Utilization management reform in Medicare -Increasing Medication Access for Seniors Act (H.R.6401) -End Coverage with Evidence Development for Alzheimer's Medications and TAVR","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":149533,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"FREY","suffix":null,"suffix_display":null},"covered_position":"Deputy Commissioner for Legislation and Congressional Affairs -- SSA, Chief of Staff -- SSA, Senior Strategic Advisor -- Office of National Drug Control Policy","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"-FY27 report language for the Food and Drug Administration on antipsychotics black box warning -FY27 report language for the Medicare Program antipsychotics measure -FY27 report language for the Medicare Prescription Payment Plan -FY27 report language for utilization management reform in the Medicare program -FY27 medical research funding -FY27 funding for FDA's Neurology Drug Program -FY 27 Appropriations H.R. 9260 and pending Senate bill, Increase Funding for Programs benefitting older adults at HHS, including ASPE, NIH, CDC HRSA, ARHQ, FDA, CMS, ACL -FY 27 Appropriations - oppose OMB uniform Guidance on federal grantmaking","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":149533,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"FREY","suffix":null,"suffix_display":null},"covered_position":"Deputy Commissioner for Legislation and Congressional Affairs -- SSA, Chief of Staff -- SSA, Senior Strategic Advisor -- Office of National Drug Control Policy","new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/aa6e8d3b-0083-433e-b273-fc754083982f/","filing_uuid":"aa6e8d3b-0083-433e-b273-fc754083982f","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/aa6e8d3b-0083-433e-b273-fc754083982f/print/","filing_document_content_type":"text/html","income":null,"expenses":"50000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"PAUL LEO HILLIAR III","dt_posted":"2026-10-20T09:02:18-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"200 Liberty Street","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"New York","registrant_state":"NY","registrant_zip":"10281","registrant":{"id":401104747,"url":"https://lda.gov/api/v1/registrants/401104747/","house_registrant_id":null,"name":"WILLIS NORTH AMERICA INC.","description":"Global advisory, broking, and solutions company.","address_1":"200 Liberty Street","address_2":null,"address_3":null,"address_4":null,"city":"New York","state":"NY","state_display":"New York","zip":"10281","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"PAUL LEO HILLIAR III","contact_telephone":"+1 202-246-8116","dt_updated":"2026-07-30T09:21:36.067183-04:00"},"client":{"id":202608,"url":"https://lda.gov/api/v1/clients/202608/","client_id":12,"name":"WILLIS NORTH AMERICA INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"NY","state_display":"New York","country":"US","country_display":"United States of America","ppb_state":"NY","ppb_state_display":"New York","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2018-01-26"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to the implementation of the Patient Protection and Affordable Care Act (PL 111-148). H.R. 5463 - CHOICE Arrangement Act, S. 2875 - Custom Health Option and Individual Care Expense (CHOICE) Act: Provisions related to Health Reimbursement Arrangements. H.R. 8324 - Great American Healthcare Plan: Provisions related to Health Savings Accounts. H.R. 7895 - PBM Kickback Prohibition Act: Provisions related to prescription drugs.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":67708,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"HILLIAR","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues related to the implementation of the Consolidated Appropriations Act (PL 117-328).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":67708,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"HILLIAR","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"RET","general_issue_code_display":"Retirement","description":"H.R. 1013, S. 424 - Retirement Fairness for Charities and Educational Institutions Act of 2025: Provisions related to retirement. P.L. 116-94 - Issues related to implementation of pooled employer retirement plans.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":67708,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"HILLIAR","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/40da8d86-4e7b-425f-8f96-82a2b874d369/","filing_uuid":"40da8d86-4e7b-425f-8f96-82a2b874d369","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/40da8d86-4e7b-425f-8f96-82a2b874d369/print/","filing_document_content_type":"text/html","income":null,"expenses":"3203049.00","expenses_method":"C","expenses_method_display":"C","posted_by_name":"Jonathan Heafitz","dt_posted":"2026-10-20T10:28:03-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"505 9th Street NW","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":31348,"url":"https://lda.gov/api/v1/registrants/31348/","house_registrant_id":34004,"name":"PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION","description":"Issues relating to prescription drug benefits","address_1":"325 7th Street NW, 9th Floor","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JONATHAN HEAFITZ","contact_telephone":"+1 202-756-5735","dt_updated":"2026-07-22T16:58:34.643878-04:00"},"client":{"id":138221,"url":"https://lda.gov/api/v1/clients/138221/","client_id":12,"name":"PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION","general_description":"no change","client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-07-01"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"S.1637/H.R 7871; Medicaid VBPs for Patients Act S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S. 2617/H.R. 1244; Reducing Drug Prices for Seniors Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 1041; Affordable Prescriptions for Patients Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3345; PBM Price Transparency and Accountability Act S.4323/ H.R. 8143; Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026 S. 5586; Ensuring Accurate Payments to Specialty Pharmacies Act H.R. 4317; PBM Reform Act H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services H.R. 9393; Lower Costs, More Transparency Act H.R. 9645; Health Care Price Certainty for All Americans Act H.R. 10369; Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":44250,"prefix":"mr","prefix_display":"MR.","first_name":"JONATHAN","nickname":null,"middle_name":"M","last_name":"HEAFITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143598,"prefix":null,"prefix_display":null,"first_name":"LUCIA","nickname":null,"middle_name":null,"last_name":"LEBENS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147046,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"THREADGILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149676,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"BUSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153596,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MARIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S.1637/H.R 7871; Medicaid VBPs for Patients Act S. 4323/ H.R. 8143; Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026 S. 2355/H.R. 5582; Patients Deserve Price Tags Act S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S.4509/ H.R. 8779; Patients Before Monopolies Act S.2276/ H.R. 3269; Eliminating Thickets to Improve Competition Act S. 526; Pharmacy Benefit Manager Transparency Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 1041; Affordable Prescriptions for Patients Act S. 1095; Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act S. 1096; Preserve Access to Affordable Generics and Biosimilars Act S. 1097; Interagency Patent Coordination and Improvements Act of 2025 S. 1414; Expedited Access to Biosimilars Act S. 2617; Reducing Drug Prices for Seniors Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3345; PBM Price Transparency and Accountability Act S. 3349; PBM Disclosure Act S. 3549; PBM Fiduciary, Accountability, Integrity, and Reform Act S. 3822; Break Up Big Medicine Act S. 4189; INSLUN Act of 2026 S. 5586; Ensuring Accurate Payments to Specialty Pharmacies Act H.R. 1244; Reducing Drug Prices for Seniors Act H.R. 2214; Delinking Revenue from Unfair Gouging Act H.R. 4317; PBM Reform Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 4570; Interagency Patent Coordination and Improvements Act of 2025 H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program H.R. 6837; To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services oSec. 6702- Full Rebate Pass Through to Plans H.R. 7895; PBM Kickback Prohibition Act H.R. 8324; Great American Healthcare Plan H.R. 9228; Health Data Access, Transparency, and Affordability Act of 2026 H.R. 9486; Health Data Access, Transparency and Affordability Act H.R. 9117; Clear Healthcare Expense Cost Knowledge Act H.R. 9393; Lower Cost, More Transparency Act of 2026 H.R. 9645; Health Care Price Certainty for All Americans Act H.R. 10369; Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":44250,"prefix":"mr","prefix_display":"MR.","first_name":"JONATHAN","nickname":null,"middle_name":"M","last_name":"HEAFITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143598,"prefix":null,"prefix_display":null,"first_name":"LUCIA","nickname":null,"middle_name":null,"last_name":"LEBENS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147046,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"THREADGILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149676,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"BUSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153596,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MARIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"},{"id":90,"name":"Small Business Administration (SBA)"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S.4509/ H.R. 8779; Patients Before Monopolies Act S. 526; Pharmacy Benefit Manager Transparency Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3822; Break Up Big Medicine Act S. 4189; INSLUN Act of 2026 S. 5586; Ensuring Accurate Payments to Specialty Pharmacies Act H.R. 1244; Reducing Drug Prices for Seniors Act H.R. 4317; PBM Reform Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services H.R. 9645; Health Care Price Certainty for All Americans Act H.R. 10369; Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":44250,"prefix":"mr","prefix_display":"MR.","first_name":"JONATHAN","nickname":null,"middle_name":"M","last_name":"HEAFITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143598,"prefix":null,"prefix_display":null,"first_name":"LUCIA","nickname":null,"middle_name":null,"last_name":"LEBENS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147046,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"THREADGILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149676,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"BUSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153596,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MARIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/7abb3f90-ad0e-4e56-887c-1ef2814fe5b5/","filing_uuid":"7abb3f90-ad0e-4e56-887c-1ef2814fe5b5","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/7abb3f90-ad0e-4e56-887c-1ef2814fe5b5/print/","filing_document_content_type":"text/html","income":null,"expenses":"1910000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Adam Temple","dt_posted":"2026-10-20T14:15:41-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"555 12th Street NW","registrant_address_2":"Suite 1001","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":27811,"url":"https://lda.gov/api/v1/registrants/27811/","house_registrant_id":30604,"name":"NFIB (NATIONAL FEDERATION OF INDEPENDENT BUSINESS)","description":"Lobbying on behalf of small business","address_1":"555 12th Street NW","address_2":"Suite 1001","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ADAM TEMPLE","contact_telephone":"+1 423-509-7989","dt_updated":"2026-07-30T16:06:39.961905-04:00"},"client":{"id":134461,"url":"https://lda.gov/api/v1/clients/134461/","client_id":12,"name":"NFIB (NATIONAL FEDERATION OF INDEPENDENT BUSINESS)","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2012-11-05"},"lobbying_activities":[{"general_issue_code":"SMB","general_issue_code_display":"Small Business","description":"House: H.R.1, An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14. H.R. 425, the Repealing Big Brother Overreach Act H.R.7035, the Credit Card Competition Act of 2026 H.R. 6213, the Heat Workforce Standards Act of 2025 H.R. 4776, the Standardizing Permitting and Expediting Economic Development (SPEED) Act H.R. 4366, the Save Local Business Act H.R. 3898, the Promoting Efficient Review for Modern Infrastructure Today (PERMIT) Act H.R. 3699, the Energy Choice Act H.R. 4424, the Securing Help for Involuntary Employment Loss and Displacement (SHIELD) Act H.R. 5463, the Custom Health Option and Individual Care Expense (CHOICE) Arrangement Act H.R.6703, the Lower Health Care Premiums for All Americans Act H.R. 20, the Richard L. Trumka Protecting the Right to Organize (PRO) Act H.R. 4896, the Warehouse Worker Protection Act H.R. 2743, the Raise the Wage Act H.R. 1319, the Modern Worker Empowerment Act H.R. 1566, the Right to Equitable and Professional Auto Industry Repair (REPAIR) Act H.R. 5349, the Tax Court Improvement Act H.R. 5346, the Fair and Accountable IRS Review Act H.R.5267, the American Franchise Act H.R. 2528, the Association Health Plans Act H.R. 6420, the Affordable Care Economic Stability and Small Business (ACCESS) Act H.R.1163, the Prove It Act of 2025 H.R. 5258, the Lawsuit Abuse Reduction Act of 2025 H.R. 2675, the Protecting Our Courts from Foreign Manipulation Act of 2025 H.R. 4626, the Home Appliance Protection and Affordability Act H.R.7148 - Consolidated Appropriations Act, 2026 H.R.7328 - Protecting Small Businesses from Predatory Website Lawsuits Act H.R. 6250, the Cold Weather Diesel Reliability Act of 2025 H.R. 6453, the Americans with Disabilities Act 30 Days to Comply Act H.R.7847, the Stop Unemployment Fraud Act H.R. 2528, the Association Health Plans Act H.R. 8082, the Competition and Openness in Markets to Promote Efficiency, Transparency, and Enhanced Affordability (COMPETE) Act H.R. 6538, the More Affordable Care Act H.R. 5582, the Patients Deserve Price Tags Act H.R. 5408, the Faster Labor Contracts Act H.R.8800, National Defense Authorization Act for Fiscal Year 2027 H.R.3269, Eliminating Thickets to Increase Competition (ETHIC) Act H.R. 5337, Motor Carrier Safety Selection Standard Act Consumer Financial Protection Bureau Section 1071 rule requires covered financial institutions to collect and report demographic and credit data on small business loan applications. H.R. 8415, Small Business Tax Cut Act H.R. 1897, Endangered Species (ES) Amendments Act of 2025 H.R.5166, Financial Services and General Government Appropriations Act, 2026 H.R. 1687, the Committing Leases for Energy Access Now (CLEAN) Act H.R. 6398, the Reducing and Eliminating Duplicative Environmental Regulations Act H.R. 8414, Know Your Labor Rights Act H.R. 7861, HSAs for All Act H.R. 7895, PBM Kickback Prohibition Act H.R. 9618, Diesel Engine Flexibility Act H.R. 9340, Ratepayer Protection Act H.R.1515, Guidance Out of the Darkness (GOOD) Act H.R. 10015, Great American Healthcare Act H.R. 5883, Safer Supervision Act of 2025 H.R. 1501, the Protecting Domestic Mining Act H.R. 9618, the Diesel Engine Flexibility (DEF) Act H.R. 10263, Halt Abusive Internet Lawsuits Act of 2026 H.R. 2675, the Protecting Our Courts from Foreign Manipulation H.J. Res. 210, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Nonroad Engine Pollution Control Standards; Ocean-Going Vessels At-Berth; Notice of Decision\", which would repeal an Environmental Protection Agency (EPA) rule requiring ocean-going vessels to reduce emissions while docked at California ports that increased shipping costs for energy, consumer products and inputs, and increased electricity demand and costs for small businesses and consumers. H.J. Res 213, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule issued by the Environmental Protection Agency relating to the \"California State Nonroad Engine Pollution Control Standards; Commercial Harbor Craft Regulations; Notice of Decision\", which would repeal the Environmental Protection Agencys (EPA) \"California State Nonroad Engine Pollution Control Standards; Commercial Harbor Craft Regulations; Notice of Decision\" rule which mandated that harbor vessels install more expensive zero-emissions engines. This regulation increased operating and energy costs for small businesses and consumers in California and across the country Issues relating to small business taxation Issues related to the expiring TCJA tax provisions Issues related to ADA website reforms Issues related to the minimum wage increase Issues related to \"Affordable Care Act Reform\" Issues related to Pharmacy Benefit Managers Issues related to Health Reform Issues related to regulatory reforms Issues related to Waters of United State Senate: S. 100, the Repealing Big Brother Overreach Act S.3623, the Credit Card Competition Act of 2026 S. 4427, Heat Workforce Standards Act of 2026 S. 3117, the Worker Reforming Elections for Speedy and Unimpeded Labor Talks (RESULTS) Act S. 3116, the Fairness in Filing Act S. 5213, the Union Members' Right to Know Act S.3124, the Protection on the Picket Line Act S.3128, the Worker Privacy Act S. 852, the Richard L. Trumka Protecting the Right to Organize (PRO) Act S. 2613, the Warehouse Worker Protection Act S. 844, the Faster Labor Contracts Act S. 2013, the Higher Wages for American Workers Act S. 1332, the Raise the Wage Act S. 1945, the Energy Choice Act S. 1379, the Right to Equitable and Professional Auto Industry Repair (REPAIR) Act S.2875, the Custom Health Option and Individual Care Expense (CHOICE) Act S. 1847, the Association Health Plans Act S. 3418, the Competition and Openness in Markets to Promote Efficiency, Transparency, and Enhanced Affordability (COMPETE) Act S.495, Prove it Act of 2025 S. 3264, the More Affordable Care Act S. 2355, the Patients Deserve Price Tags Act S. 4366, Know Your Labor Rights Act S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act S. 4419: A bill to amend title 31, United States Code, to require only foreign entities to report beneficial ownership information, and for other purposes. S.J. Res. 208, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Motor Vehicle Pollution Control Standards; Advanced Clean Car Program; Reconsideration of a Previous Withdrawal of a Waiver of Preemption; Notice of Decision\", which would repeal an Environmental Protection Agency (EPA) waiver granted to the California Air Resources Board (CARB), allowing the continuation of the Advanced Clean Cars (ACC) framework. These overreaching standards would have resulted in a costly and unrealistic electric vehicle mandate on small business owners and consumers nationwide. S.J. Res. 209, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Nonroad Engine Pollution Control Standards; Ocean-Going Vessels At-Berth; Notice of Decision\" which would repeal an Environmental Protection Agency (EPA) rule requiring ocean-going vessels to reduce emissions while docked at California ports. Issue relating to small business taxation S.J. Res. 206, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Motor Vehicle Pollution Control Standards; Notice of Decision Granting a Waiver of Clean Air Act Preemption for California's 2009 and Subsequent Model Year Greenhouse Gas Emission Standards for New Motor Vehicles\" which would repeal an Environmental Protection Agency (EPA) rule titled California State Motor Vehicle Pollution Control Standards; Notice of Decision Granting a Waiver of Clean Air Act [CAA] Preemption for California's 2009 and Subsequent Model Year Greenhouse Gas Emission Standards for New Motor Vehicles that increased the cost of vehicles for small businesses and consumers. S.J. Res. 207, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Motor Vehicle Pollution Control Standards; Notice of Decision Granting a Waiver of Clean Air Act Preemption for California's Advanced Clean Car Program and a Within the Scope Conformation for California's Zero Emission Vehicle Amendments for 2017 and Earlier Model Years\" which would repeal the Environmental Protection Agencys (EPA) waiver granting the California Air Resources Board (CARB) the authority to create the Advanced Clean Cars (ACC) framework. This overreaching rule increased costs for small businesses and consumers by creating a de facto electric vehicle mandate. S.J. Res. 205, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Nonroad Engine Pollution Control Standards; Small Off-Road Engines Regulations; Notice of Decision\" which would repeal the Environmental Protection Agencys (EPA) rule titled \"California State Nonroad Engine Pollution Control Standards; Small Off-Road Engines [SORE] Regulations. Issue related to the expiring TCJA tax provisions Issue related to ADA website reforms Issue related to the minimum wage increase Issue related to \"Affordable Care Act Reform\" Issue related to Pharmacy Benefits Managers Issue related to Health reform Issues related to wiretapping and eavesdropping law abuse Department of the Treasury: Beneficial Ownership Information (BOI) Reporting Rule White House: Beneficial Ownership Information (BOI) Reporting Rule Heat Injury and Illness Prevention in Outdoor and Indoor Work Settings Rule Issues related to Short-Term, Limited-Duration Insurance Plans Issues related to Health Savings Accounts Issues related to CHOICE Arrangements Healthcare Transparency Rule Vice President of the U.S.: Heat Injury and Illness Prevention in Outdoor and Indoor Work Settings Rule Department of Labor: Heat Injury and Illness Prevention in Outdoor and Indoor Work Settings Rule Issues related to Short-Term, Limited-Duration Insurance Plans Occupational Safety and Health Administration: Heat Injury and Illness Prevention in Outdoor and Indoor Work Settings Rule Small Business Administration: Beneficial Ownership Information (BOI) Reporting Rule Heat Injury and Illness Prevention in Outdoor and Indoor Work Settings Rule Issues related to Title III ADA website reforms Department Health and Human Services: Short-Term, Limited Duration Insurance Rule Individual Coverage Health Reimbursement Arrangement Rule Health Savings Account Rule","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":17374,"prefix":null,"prefix_display":null,"first_name":"BRAD","nickname":null,"middle_name":null,"last_name":"CLOSE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145069,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"TEMPLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141297,"prefix":null,"prefix_display":null,"first_name":"JOSHUA","nickname":null,"middle_name":null,"last_name":"MCLEOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146938,"prefix":null,"prefix_display":null,"first_name":"DYLAN","nickname":null,"middle_name":null,"last_name":"ROSNICK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149442,"prefix":null,"prefix_display":null,"first_name":"TYLER","nickname":null,"middle_name":null,"last_name":"DEVER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151220,"prefix":"mr","prefix_display":"MR.","first_name":"TIMOTHY","nickname":null,"middle_name":"RYAN","last_name":"NUNGESSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151564,"prefix":null,"prefix_display":null,"first_name":"LOUIS","nickname":null,"middle_name":null,"last_name":"BERTOLOTTI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153661,"prefix":null,"prefix_display":null,"first_name":"MARY","nickname":null,"middle_name":"ALEX","last_name":"HAMBY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155618,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"PARKS","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":167,"name":"Occupational Safety & Health Administration (OSHA)"},{"id":1,"name":"SENATE"},{"id":90,"name":"Small Business Administration (SBA)"},{"id":41,"name":"Treasury, Dept of"},{"id":10,"name":"Vice President of the U.S."},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/28469589-c436-4ea0-8163-918817f2f498/","filing_uuid":"28469589-c436-4ea0-8163-918817f2f498","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/28469589-c436-4ea0-8163-918817f2f498/print/","filing_document_content_type":"text/html","income":null,"expenses":"370000.00","expenses_method":"C","expenses_method_display":"C","posted_by_name":"Anne Cassity","dt_posted":"2026-10-21T07:04:51-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"100 DAINGERFIELD ROAD","registrant_address_2":"3rd FLOOR","registrant_different_address":false,"registrant_city":"ALEXANDRIA","registrant_state":"VA","registrant_zip":"22314","registrant":{"id":27478,"url":"https://lda.gov/api/v1/registrants/27478/","house_registrant_id":30354,"name":"NATIONAL COMMUNITY PHARMACISTS ASSOCIATION","description":null,"address_1":"100 DAINGERFIELD ROAD","address_2":"3rd FLOOR","address_3":null,"address_4":null,"city":"ALEXANDRIA","state":"VA","state_display":"Virginia","zip":"22314","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ANNE CASSITY","contact_telephone":"+1 703-683-8200","dt_updated":"2026-07-28T10:07:13.835223-04:00"},"client":{"id":134293,"url":"https://lda.gov/api/v1/clients/134293/","client_id":12,"name":"NATIONAL COMMUNITY PHARMACISTS ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2008-02-13"},"lobbying_activities":[{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Comments to CBP on \"June 14, 2024, Internal Advice Letter H283420\"; Comments to on \"Re: Notice of Request for Public Comments on Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients [XRIN 0694- XC120]\";","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63794,"prefix":null,"prefix_display":null,"first_name":"RONNA","nickname":null,"middle_name":null,"last_name":"HAUSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145270,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":"STEVE","middle_name":"W","last_name":"POSTAL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26125,"prefix":null,"prefix_display":null,"first_name":"ANNE","nickname":null,"middle_name":null,"last_name":"CASSITY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":184,"name":"U.S. Customs & Border Protection"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"SMB","general_issue_code_display":"Small Business","description":"Comments to the White House on the Corporate Transparency Act implementations (NDAA; P.L.116-283); Comments to Treasury on the Corporate Transparency Act implementations (NDAA; P.L.116-283);","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63794,"prefix":null,"prefix_display":null,"first_name":"RONNA","nickname":null,"middle_name":null,"last_name":"HAUSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145270,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":"STEVE","middle_name":"W","last_name":"POSTAL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26125,"prefix":null,"prefix_display":null,"first_name":"ANNE","nickname":null,"middle_name":null,"last_name":"CASSITY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":41,"name":"Treasury, Dept of"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"ALC","general_issue_code_display":"Alcohol and Drug Abuse","description":"Controlled Substances Prescribing & Dispensing; Comments to DOJ & DEA on \"Ensuring Lawful Governance and Implementing the Presidents 'Department of Government Efficiency' Deregulatory Initiative\"; Comments to DEA on \"Special Registrations for Telemedicine and Limited State Telemedicine Registrations [Docket No. DEA-407]\" Comments to DEA on \"Update to DEA Registration Process for Pharmacists to Reflect State Law Changes\"","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63794,"prefix":null,"prefix_display":null,"first_name":"RONNA","nickname":null,"middle_name":null,"last_name":"HAUSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26125,"prefix":null,"prefix_display":null,"first_name":"ANNE","nickname":null,"middle_name":null,"last_name":"CASSITY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142063,"prefix":null,"prefix_display":null,"first_name":"KAITLIN","nickname":null,"middle_name":null,"last_name":"KRELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145270,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":"STEVE","middle_name":"W","last_name":"POSTAL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148025,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"JEREMY","last_name":"WEISSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":37,"name":"Justice, Dept of (DOJ)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"S.891, the Bipartisan Health Care Act; S.882, the Patients Before Middlemen Act; S.927, the Protecting Pharmacies in Medicaid Act; H.R.3164/S.2426, the Mainstreet Pharmacy Access Act/the Ensuring Community Access to Pharmacist Services Act; H.R.2428, the Ensuring Access to Lower-Cost Medicines for Seniors Act; Comments to CMS on the implementation of Medicare Part D Medicare Drug Price Negotiation implementation under the Inflation Reduction Act (IRA; P.L. 117-169); Long-Term Care Pharmacy at Home Services in Medicare; Comments to CMS for its \"Dispensing Entity-CMS Agreement and Dispensing Entity-MTF Data Module Contractor Agreement\" (IRA; P.L.117-169)' H.R.1, the One Big Beautiful Bill Act Comments to CMS on \"Re: Draft Guidance for IPAY 2028 and Manufacturer Effectuation of the MFP for 2026, 2027, and 2028 for the Medicare Drug Price Negotiation Program\"; Comments to CMS on \"Re: Medicare Transaction Facilitator DRAFT Standard Companion Guide Health Care Claim Payment/Advice (835)\" Comments to CMS on \"Re: Agency Information Collection Activities: Proposed Collection; Comment Request [Docket No. CMS-10912] - CMS-10912 Medicare Transaction Facilitator for 2026 and 2027 under Sections 11001 and 11002 of the Inflation Reduction Act (IRA) - Drug Price Negotiation Program MTF DM Dispensing Entity and Third-Party Support Enrollment Form\"; H.Con.Res.14, Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.4317, the PBM Reform Act; H.R.5031/S.3159, the Preserving Patient Access to Long-Term Care Pharmacies Act; Comments to CMS on \"RE:Re: Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model [CMS-1830-P]\"; Comments to CMS on \"Re: Medicare and Medicaid Programs; Calendar Year 2026 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the HH Value-Based Purchasing Expanded Model; Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program Updates; DMEPOS Accreditation Requirements; Provider Enrollment; and Other Medicare and Medicaid Policies [CMS-1828-P]\"; Comments to CMS on \"RE:Re: 340B Program Notice: Application Process for the 340B Rebate Model Pilot Program [HRSA2025 and HRSA-2025-14619]\"; Comments to CMS on \"Re: Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program [CMS-1832-P]\"; H.R.5256, the 340B ACCESS Act; S.2800, the Pharmacy and Medically Underserved Areas Enhancement Act; S.3345, the PBM Price Transparency and Accountability Act; H.R. 6609, Pharmacists Fight Back in Medicare and Medicaid Act; Grassley-Lujan Request-for-Information on Pharmacists Providing Chronic Care; CMMI Potential reimbursement model for CMS coverage of GLP-1 drugs; H.R.7148, the Consolidated Appropriations Act, 2026; Comments to CMS on Proposed Rule \"Re: Medicare Program; Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program\"; Implementation of \"reasonable and relevant\" contract terms in the Medicare Part D Program; Comments to CMS on \"Re: Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; Interoperability Standards and Prior Authorization for Drugs for Medicare Advantage Organizations, Medicaid Managed Care Plans, State Medicaid Agencies, Childrens Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, and Issuers of Qualified Health Plans on the Federally-Facilitated Exchanges [CMS-0062-P]\"; Comments to CMS on \"Re: Medicare GLP-1 Bridge Program - Improper Restriction of the $5.00 LTC Dispensing Fee to Nursing Facility and ICF/IID Residents; Conflict with 42 C.F.R. 423.120, Chapter 5, Section 20.7 of the Medicare Prescription Drug Benefit Manual, and CMSs December 15, 2021 Guidance on LTC Pharmacy Access\"; Comments to CMS on \"Re: Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program [CMS-4215-P]\"; Comments to CMS on \"Re: Medicare and Medicaid Programs; CY 2027 Payment Policies under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings [CMS-1848-P]\"; S. 5496, Health CARE Act of 2026; S. 5586, Ensuring Accurate Payments to Specialty Pharmacies Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63794,"prefix":null,"prefix_display":null,"first_name":"RONNA","nickname":null,"middle_name":null,"last_name":"HAUSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26125,"prefix":null,"prefix_display":null,"first_name":"ANNE","nickname":null,"middle_name":null,"last_name":"CASSITY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142063,"prefix":null,"prefix_display":null,"first_name":"KAITLIN","nickname":null,"middle_name":null,"last_name":"KRELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145270,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":"STEVE","middle_name":"W","last_name":"POSTAL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148025,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"JEREMY","last_name":"WEISSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"H.R. 2214, the Delinking Revenue from Unfair Gouging Act; H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.Con.Res 14/S. Con. Res. 7, Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R. 1, the One Big Beautiful Bill; Comments to FDA on \"Re: Agency Information Collection Activities; Proposed Collection; Comment Request; Compounding Animal Drugs From Bulk Drug Substances [Docket No. FDA-2025-N-0082]\"; LHHS Report Language Request to Improve the Care and Treatment of Long-Term Care Residents with Neuropsychiatric Symptoms; Comments to OMB on \"Re: Request for Information: Deregulation\"; Comments to HHS/DOGE on government efficiency, fraud, waste and PBMs; Comments on \"Executive Order 14297 of May 12, 2025 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients\"; Comments to CDC on \"RE: June 25-26 Advisory Committee on Immunization Practices Meeting\"; H.R.5316, the Drug Shortage Compounding and Patient Access Act; H.R.5256, the 340B ACCESS Act; Comments to FDA on \"RE: Docket No. FDA-2025-N-2589, Comments on the Risks and Benefits of Menopause Hormone Therapy\"; H.Res. 805, Recognizing October 2025 as American Pharmacists Month in honor of the contribution of pharmacists to provide safe, accessible, affordable, and beneficial patient care services and products to all residents and protect the public health of our communities; S.3345, the PBM Price Transparency and Accountability Act; H.R. 6609, Pharmacists Fight Back in Medicare and Medicaid Act; H.R. 6610, Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act]; H.R. 6703, the Lower Health Care Premiums for All Americans Act; H.R.5133, the Patient's Right to Know Their Medication Act; H.R. 4409, the Fair Pharmacies for Federal Employees Act; S.3549/H.R.6837, the Fiduciary Accountability, Integrity and Reform (FAIR) Act; H.R.7148, the Consolidated Appropriations Act of 2026; Rural Health Transformation Program; Creation and Implementation of TrumpRx; Comments to FDA on RFI, \"Re: Increasing Access to Nonprescription Drugs; Request for Information\"; S.3822, Break up Big Medicine Act; Comments to FDA on RFT, \"Re: [Docket No. FDA-2025-N-6743] - Scientific and Clinical Considerations for Testosterone Replacement Therapy (TRT) in Men with Hypogonadism\"; Comments to DoL, HHS, and DoT regarding \"Re: Transparency in Coverage Proposed Rule [CMS-9882-P]\"; Pharmacy Shortage Areas in reference to USC-NCPA joint project Mapping Tool; H.R. 7895, the PBM Kickback Prohibition Act; Comments to FDA on their comment request \"Re: Agency Information Collection Activities; Proposed Collection; Comment Request; Medication Guides for Prescription Drug Products [FDA-2025-N-6869]\"; H.R.6509/S.3794, the SAFE Drug Act; H.R.5316, the Drug Shortage Compounding Patient Access Act; H.R.8779/S.4509, the Patients Before Monopolies Act; S.3788/H.R.8269, the CLEAR LABELS Act; S.1941, the Cure Hepatitis C Act of 2025; Comments to Senate Finance \"Re: Request for Information: Commonsense Policy Options to Lower Drug Prices for Patients\"; H.R. 8630, the PEAT Act; Comments to HHS, ASPE on \"RE: Docket No. HHS-OS-2026-0332 for Request for Information: Categories Used in Federal Vaccine Recommendations and the Role of Shared Clinical Decision-Making; H.R. 10369, Net Effective Cost Transparency and Prescription Drug Affordability Act;","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63794,"prefix":null,"prefix_display":null,"first_name":"RONNA","nickname":null,"middle_name":null,"last_name":"HAUSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26125,"prefix":null,"prefix_display":null,"first_name":"ANNE","nickname":null,"middle_name":null,"last_name":"CASSITY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142063,"prefix":null,"prefix_display":null,"first_name":"KAITLIN","nickname":null,"middle_name":null,"last_name":"KRELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145270,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":"STEVE","middle_name":"W","last_name":"POSTAL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148025,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"JEREMY","last_name":"WEISSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":40,"name":"Transportation, Dept of (DOT)"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"S.587/1301, The Death Tax Repeal Act;","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63794,"prefix":null,"prefix_display":null,"first_name":"RONNA","nickname":null,"middle_name":null,"last_name":"HAUSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26125,"prefix":null,"prefix_display":null,"first_name":"ANNE","nickname":null,"middle_name":null,"last_name":"CASSITY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142063,"prefix":null,"prefix_display":null,"first_name":"KAITLIN","nickname":null,"middle_name":null,"last_name":"KRELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148025,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"JEREMY","last_name":"WEISSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"LBR","general_issue_code_display":"Labor Issues/Antitrust/Workplace","description":"S.526, the Pharmacy Benefit Manager Transparency Act of 2025; S.527, the Prescription Pricing for the People Act of 2025; Comments to Department of Labor RE: \"Re: Reforming Pharmacy Benefit Manager (PBM) Compensation Practices\"; H.R.7895, the PBM Kickback Prohibition Act; Comments to DOL on \"Re: Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure [RIN 1210-AB37]\"' Comments to DOJ on \"Re: NCPA Comment on Competitor Collaboration Guidance (Docket No. ATR-2026- 0001)\"' H.R.8779/S.4509, the Patients Before Monopolies Act;","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63794,"prefix":null,"prefix_display":null,"first_name":"RONNA","nickname":null,"middle_name":null,"last_name":"HAUSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26125,"prefix":null,"prefix_display":null,"first_name":"ANNE","nickname":null,"middle_name":null,"last_name":"CASSITY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142063,"prefix":null,"prefix_display":null,"first_name":"KAITLIN","nickname":null,"middle_name":null,"last_name":"KRELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148025,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"JEREMY","last_name":"WEISSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":64,"name":"Federal Trade Commission (FTC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"TRICARE Pharmacy Network Oversight & Changes; H.R.8800/S.4784, the National Defense Authorization Act for Fiscal Year 2027; H.R. 6400/S.4106,the RxACCESS Act; Veterans Affairs Health Pharmacy Program;","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63794,"prefix":null,"prefix_display":null,"first_name":"RONNA","nickname":null,"middle_name":null,"last_name":"HAUSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26125,"prefix":null,"prefix_display":null,"first_name":"ANNE","nickname":null,"middle_name":null,"last_name":"CASSITY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142063,"prefix":null,"prefix_display":null,"first_name":"KAITLIN","nickname":null,"middle_name":null,"last_name":"KRELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148025,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"JEREMY","last_name":"WEISSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.Con.Res 14/S. Con. Res. 7, Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.1, the One Big Beautiful Bill Act; H.R.5304, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; H.R.7148, the Consolidated Appropriations Act of 2026;","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63794,"prefix":null,"prefix_display":null,"first_name":"RONNA","nickname":null,"middle_name":null,"last_name":"HAUSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26125,"prefix":null,"prefix_display":null,"first_name":"ANNE","nickname":null,"middle_name":null,"last_name":"CASSITY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142063,"prefix":null,"prefix_display":null,"first_name":"KAITLIN","nickname":null,"middle_name":null,"last_name":"KRELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148025,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"JEREMY","last_name":"WEISSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TEC","general_issue_code_display":"Telecommunications","description":"Comments to HHS on \"HIPAA Security Rule To Strengthen the Cybersecurity of Electronic Protected Health Information [HHS-OCR-0945-AA22]\";","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":26125,"prefix":null,"prefix_display":null,"first_name":"ANNE","nickname":null,"middle_name":null,"last_name":"CASSITY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63794,"prefix":null,"prefix_display":null,"first_name":"RONNA","nickname":null,"middle_name":null,"last_name":"HAUSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142063,"prefix":null,"prefix_display":null,"first_name":"KAITLIN","nickname":null,"middle_name":null,"last_name":"KRELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145270,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":"STEVE","middle_name":"W","last_name":"POSTAL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148025,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"JEREMY","last_name":"WEISSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}]}